<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.2?>
<?ConverterInfo.XSLTName jats2jats3.xsl?>
<?ConverterInfo.Version 1?>
<?properties open_access?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Bioinformatics</journal-id>
    <journal-id journal-id-type="iso-abbrev">Bioinformatics</journal-id>
    <journal-id journal-id-type="publisher-id">bioinformatics</journal-id>
    <journal-title-group>
      <journal-title>Bioinformatics</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">1367-4803</issn>
    <issn pub-type="epub">1367-4811</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">10955249</article-id>
    <article-id pub-id-type="pmid">38426335</article-id>
    <article-id pub-id-type="doi">10.1093/bioinformatics/btae114</article-id>
    <article-id pub-id-type="publisher-id">btae114</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Applications Note</subject>
        <subj-group subj-group-type="category-toc-heading">
          <subject>Genome Analysis</subject>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="category-taxonomy-collection">
        <subject>AcademicSubjects/SCI01060</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>AutoGVP: a dockerized workflow integrating ClinVar and InterVar germline sequence variant classification</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-6274-2841</contrib-id>
        <name>
          <surname>Kim</surname>
          <given-names>Jung</given-names>
        </name>
        <aff><institution>Division of Cancer Epidemiology and Genetics, National Cancer Institute</institution>, Rockville, MD 20850, <country country="US">United States</country></aff>
        <xref rid="btae114-FM1" ref-type="author-notes"/>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Naqvi</surname>
          <given-names>Ammar S</given-names>
        </name>
        <aff><institution>Center for Data-Driven Discovery in Biomedicine, Children’s Hospital of Philadelphia</institution>, Philadelphia, PA 19104, <country country="US">United States</country></aff>
        <aff><institution>Division of Neurosurgery, Children’s Hospital of Philadelphia</institution>, Philadelphia, PA 19104, <country country="US">United States</country></aff>
        <xref rid="btae114-FM1" ref-type="author-notes"/>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Corbett</surname>
          <given-names>Ryan J</given-names>
        </name>
        <aff><institution>Center for Data-Driven Discovery in Biomedicine, Children’s Hospital of Philadelphia</institution>, Philadelphia, PA 19104, <country country="US">United States</country></aff>
        <aff><institution>Division of Neurosurgery, Children’s Hospital of Philadelphia</institution>, Philadelphia, PA 19104, <country country="US">United States</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Kaufman</surname>
          <given-names>Rebecca S</given-names>
        </name>
        <aff><institution>Department of Bioinformatics and Health Informatics, Children’s Hospital of Philadelphia</institution>, Philadelphia, PA 19104, <country country="US">United States</country></aff>
        <aff><institution>Division of Oncology, Children's Hospital of Philadelphia</institution>, Philadelphia, PA 19104, <country country="US">United States</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Vaksman</surname>
          <given-names>Zalman</given-names>
        </name>
        <aff><institution>Department of Bioinformatics and Health Informatics, Children’s Hospital of Philadelphia</institution>, Philadelphia, PA 19104, <country country="US">United States</country></aff>
        <aff><institution>Division of Oncology, Children's Hospital of Philadelphia</institution>, Philadelphia, PA 19104, <country country="US">United States</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Brown</surname>
          <given-names>Miguel A</given-names>
        </name>
        <aff><institution>Center for Data-Driven Discovery in Biomedicine, Children’s Hospital of Philadelphia</institution>, Philadelphia, PA 19104, <country country="US">United States</country></aff>
        <aff><institution>Division of Neurosurgery, Children’s Hospital of Philadelphia</institution>, Philadelphia, PA 19104, <country country="US">United States</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Miller</surname>
          <given-names>Daniel P</given-names>
        </name>
        <aff><institution>Center for Data-Driven Discovery in Biomedicine, Children’s Hospital of Philadelphia</institution>, Philadelphia, PA 19104, <country country="US">United States</country></aff>
        <aff><institution>Division of Neurosurgery, Children’s Hospital of Philadelphia</institution>, Philadelphia, PA 19104, <country country="US">United States</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-2771-2572</contrib-id>
        <name>
          <surname>Phul</surname>
          <given-names>Saksham</given-names>
        </name>
        <aff><institution>Center for Data-Driven Discovery in Biomedicine, Children’s Hospital of Philadelphia</institution>, Philadelphia, PA 19104, <country country="US">United States</country></aff>
        <aff><institution>Division of Neurosurgery, Children’s Hospital of Philadelphia</institution>, Philadelphia, PA 19104, <country country="US">United States</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Geng</surname>
          <given-names>Zhuangzhuang</given-names>
        </name>
        <aff><institution>Center for Data-Driven Discovery in Biomedicine, Children’s Hospital of Philadelphia</institution>, Philadelphia, PA 19104, <country country="US">United States</country></aff>
        <aff><institution>Division of Neurosurgery, Children’s Hospital of Philadelphia</institution>, Philadelphia, PA 19104, <country country="US">United States</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Storm</surname>
          <given-names>Phillip B</given-names>
        </name>
        <aff><institution>Center for Data-Driven Discovery in Biomedicine, Children’s Hospital of Philadelphia</institution>, Philadelphia, PA 19104, <country country="US">United States</country></aff>
        <aff><institution>Division of Neurosurgery, Children’s Hospital of Philadelphia</institution>, Philadelphia, PA 19104, <country country="US">United States</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Resnick</surname>
          <given-names>Adam C</given-names>
        </name>
        <aff><institution>Center for Data-Driven Discovery in Biomedicine, Children’s Hospital of Philadelphia</institution>, Philadelphia, PA 19104, <country country="US">United States</country></aff>
        <aff><institution>Division of Neurosurgery, Children’s Hospital of Philadelphia</institution>, Philadelphia, PA 19104, <country country="US">United States</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Stewart</surname>
          <given-names>Douglas R</given-names>
        </name>
        <aff><institution>Division of Cancer Epidemiology and Genetics, National Cancer Institute</institution>, Rockville, MD 20850, <country country="US">United States</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-2171-3627</contrib-id>
        <name>
          <surname>Rokita</surname>
          <given-names>Jo Lynne</given-names>
        </name>
        <aff><institution>Center for Data-Driven Discovery in Biomedicine, Children’s Hospital of Philadelphia</institution>, Philadelphia, PA 19104, <country country="US">United States</country></aff>
        <aff><institution>Division of Neurosurgery, Children’s Hospital of Philadelphia</institution>, Philadelphia, PA 19104, <country country="US">United States</country></aff>
        <xref rid="btae114-FM2" ref-type="author-notes"/>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-7200-8939</contrib-id>
        <name>
          <surname>Diskin</surname>
          <given-names>Sharon J</given-names>
        </name>
        <aff><institution>Department of Bioinformatics and Health Informatics, Children’s Hospital of Philadelphia</institution>, Philadelphia, PA 19104, <country country="US">United States</country></aff>
        <aff><institution>Division of Oncology, Children's Hospital of Philadelphia</institution>, Philadelphia, PA 19104, <country country="US">United States</country></aff>
        <aff><institution>Department of Pediatrics, University of Pennsylvania</institution>, Philadelphia, PA 19104, <country country="US">United States</country></aff>
        <xref rid="btae114-FM2" ref-type="author-notes"/>
        <xref rid="btae114-cor1" ref-type="corresp"/>
        <!--diskin@chop.edu-->
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name>
          <surname>Alkan</surname>
          <given-names>Can</given-names>
        </name>
        <role>Associate Editor</role>
      </contrib>
    </contrib-group>
    <author-notes>
      <corresp id="btae114-cor1">Corresponding author. Sharon J. Diskin, Department of Bioinformatics and Health Informatics, 3026 Colket Translational Research Building, Center for Childhood Cancer Research, Children's Hospital of Philadelphia, PA 19104, United States. E-mail: <email>diskin@chop.edu</email></corresp>
      <fn id="btae114-FM1">
        <p>Jung Kim and Ammar S. Naqvi Equal contribution first authorship.</p>
      </fn>
      <fn id="btae114-FM2">
        <p>Jo Lynne Rokita and Sharon J. Diskin Equal senior contribution.</p>
      </fn>
    </author-notes>
    <pub-date pub-type="collection">
      <month>3</month>
      <year>2024</year>
    </pub-date>
    <pub-date pub-type="epub" iso-8601-date="2024-02-29">
      <day>29</day>
      <month>2</month>
      <year>2024</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>29</day>
      <month>2</month>
      <year>2024</year>
    </pub-date>
    <volume>40</volume>
    <issue>3</issue>
    <elocation-id>btae114</elocation-id>
    <history>
      <date date-type="received">
        <day>30</day>
        <month>11</month>
        <year>2023</year>
      </date>
      <date date-type="rev-recd">
        <day>09</day>
        <month>2</month>
        <year>2024</year>
      </date>
      <date date-type="editorial-decision">
        <day>19</day>
        <month>2</month>
        <year>2024</year>
      </date>
      <date date-type="accepted">
        <day>27</day>
        <month>2</month>
        <year>2024</year>
      </date>
      <date date-type="corrected-typeset">
        <day>20</day>
        <month>3</month>
        <year>2024</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2024. Published by Oxford University Press.</copyright-statement>
      <copyright-year>2024</copyright-year>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
      </license>
    </permissions>
    <self-uri xlink:href="btae114.pdf"/>
    <abstract>
      <title>Abstract</title>
      <sec id="s1">
        <title>Summary</title>
        <p>With the increasing rates of exome and whole genome sequencing, the ability to classify large sets of germline sequencing variants using up-to-date American College of Medical Genetics—Association for Molecular Pathology (ACMG-AMP) criteria is crucial. Here, we present Automated Germline Variant Pathogenicity (AutoGVP), a tool that integrates germline variant pathogenicity annotations from ClinVar and sequence variant classifications from a modified version of InterVar (PVS1 strength adjustments, removal of PP5/BP6). This tool facilitates large-scale, clinically focused classification of germline sequence variants in a research setting.</p>
      </sec>
      <sec id="s2">
        <title>Availability and implementation</title>
        <p>AutoGVP is an open source dockerized workflow implemented in R and freely available on GitHub at <ext-link xlink:href="https://github.com/diskin-lab-chop/AutoGVP" ext-link-type="uri">https://github.com/diskin-lab-chop/AutoGVP</ext-link>.</p>
      </sec>
    </abstract>
    <funding-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>National Institutes of Health</institution>
            <institution-id institution-id-type="DOI">10.13039/100000002</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>R03CA230366</award-id>
        <award-id>R01CA237562</award-id>
        <award-id>U2CHL138346</award-id>
        <award-id>R03CA287169</award-id>
      </award-group>
    </funding-group>
    <counts>
      <page-count count="4"/>
    </counts>
  </article-meta>
</front>
<body>
  <sec>
    <title>1 Introduction</title>
    <p>As exome and whole genome sequencing become more prevalent in clinical genetic testing and population-scale biobanks become more widely accessible, tools that facilitate classification of large sets of germline variants are crucial. Tools such as InterVar (<xref rid="btae114-B6" ref-type="bibr">Li and Wang 2017</xref>), CharGer (<xref rid="btae114-B9" ref-type="bibr">Scott <italic toggle="yes">et al.</italic> 2019</xref>), Franklin (<ext-link xlink:href="https://franklin.genoox.com" ext-link-type="uri">https://franklin.genoox.com</ext-link>), and Varsome (<xref rid="btae114-B5" ref-type="bibr">Kopanos <italic toggle="yes">et al.</italic> 2019</xref>) implement the ACMG-AMP guidelines for the interpretation of germline sequence variants (<xref rid="btae114-B8" ref-type="bibr">Richards <italic toggle="yes">et al.</italic> 2015</xref>). However, misclassification of variant pathogenicity may occur depending on the interpretation of specific ACMG-AMP criteria set by the tool at the time of the development. For example, variants can be mis-classified by applying “full strength” of the PVS1 rule (“a null variant in a gene where loss-of-function is a known mechanism of disease”), and/or use of the PP5 rule (“reputable source recently reports variant as pathogenic, but the evidence is not available to the laboratory to perform an independent evaluation”). In 2018, ACMG-AMP recommendations for PVS1 were modified so that null variants should not be considered at the same strength, but in different categories (PVS1, PVS1_Strong, PVS1_Moderate, PVS1_Supporting) (<xref rid="btae114-B1" ref-type="bibr">Abou Tayoun <italic toggle="yes">et al.</italic> 2018</xref>). To address the modified PVS1 rule, Xiang et al. developed AutoPVS1 to automate PVS1 adjustments (<xref rid="btae114-B1" ref-type="bibr">Abou Tayoun <italic toggle="yes">et al.</italic> 2018</xref>, <xref rid="btae114-B12" ref-type="bibr">Xiang <italic toggle="yes">et al.</italic> 2020</xref>). Furthermore, some tools are limited in the number of variants that can be classified at once or require the purchase of a license.</p>
    <p>InterVar reports each ACMG-AMP criterion with a score and each criterion is easily modifiable using open-source code accessible through GitHub. Concomitant with the development of these tools has been the dramatic increase in both the quantity and quality of germline variant classifications within the ClinVar database. This is due to the collaborative effort of ClinGen variant curation expert panels (<xref rid="btae114-B7" ref-type="bibr">Rehm <italic toggle="yes">et al.</italic> 2015</xref>) which meticulously refine, on a gene-specific basis, ACMG-AMP criteria using clinical (phenotype) information, the underlying biology of a gene (and structure of associated protein(s)), bioinformatics predictions and population genetics. It is important to note that (as of November 2023) InterVar does <italic toggle="yes">not</italic> automatically incorporate classification rules developed by ClinGen Variant Curation Expert Panels (VCEP; <ext-link xlink:href="https://clinicalgenome.org/affiliation/vcep/" ext-link-type="uri">https://clinicalgenome.org/affiliation/vcep/</ext-link>). In addition, ClinVar will only have variants that have been curated and deposited. There is a need for a comprehensive pipeline that not only annotates patient germline variation deposited to ClinVar, but also those not documented in ClinVar.</p>
    <p>We created the Automated Germline Variant Pathogenicity (AutoGVP) pipeline to classify germline variant pathogenicity in research settings through integrating both ClinVar and InterVar annotations. Uniquely, AutoGVP automatically modifies InterVar to classify variants using most current ACMG-AMP guidelines, by adjusting PVS1 strength (<xref rid="btae114-B7" ref-type="bibr">Rehm <italic toggle="yes">et al.</italic> 2015</xref>, <xref rid="btae114-B1" ref-type="bibr">Abou Tayoun <italic toggle="yes">et al.</italic> 2018</xref>), using autoPVS1 and removing the PP5 and BP6 rules (<xref rid="btae114-B3" ref-type="bibr">Biesecker <italic toggle="yes">et al.</italic> 2018</xref>). Adjusting PVS1 strength is crucial since InterVar can over-interpret loss-of-function (LOF) variants (<xref rid="btae114-B10" ref-type="bibr">Singer-Berk <italic toggle="yes">et al.</italic> 2023</xref>) as it classifies all LOF variants that are in LOF-intolerant genes curated by InterVar as PVS1 (<xref rid="btae114-B6" ref-type="bibr">Li and Wang 2017</xref>). AutoGVP can classify any number of variants in standard VCF format. The code is freely available as a dockerized workflow in GitHub (<ext-link xlink:href="https://github.com/diskin-lab-chop/AutoGVP" ext-link-type="uri">https://github.com/diskin-lab-chop/AutoGVP</ext-link>) with options of (1) supply a VEP-annotated VCF with ANNOVAR (<xref rid="btae114-B11" ref-type="bibr">Wang <italic toggle="yes">et al.</italic> 2010</xref>), AutoPVS1 (<xref rid="btae114-B12" ref-type="bibr">Xiang <italic toggle="yes">et al.</italic> 2020</xref>), and InterVar (<xref rid="btae114-B6" ref-type="bibr">Li and Wang 2017</xref>) outputs with the flexibility to update any of these and/or the provided ClinVar versions or (2) use similarly-annotated (ANNOVAR, InterVar, AutoPVS1, ClinVar) output from a cloud-based CAVATICA preprocessing workflow v.1.1.0 (<ext-link xlink:href="https://github.com/d3b-center/D3b-Pathogenicity-Preprocessing" ext-link-type="uri">https://github.com/d3b-center/D3b-Pathogenicity-Preprocessing</ext-link>) and public CAVATICA app (<ext-link xlink:href="https://cavatica.sbgenomics.com/public/apps/cavatica/apps-publisher/d3b-diskin-pathogenicity-preprocess-wf" ext-link-type="uri">https://cavatica.sbgenomics.com/public/apps/cavatica/apps-publisher/d3b-diskin-pathogenicity-preprocess-wf</ext-link>) on germline calls from the Kids First pipeline v.1.1.0 (<ext-link xlink:href="https://github.com/kids-first/kf-germline-workflow" ext-link-type="uri">https://github.com/kids-first/kf-germline-workflow</ext-link>) (<xref rid="btae114-F1" ref-type="fig">Fig. 1A</xref>). Depending on sample input size, AutoGVP can be run either locally, on Amazon Web Services Elastic Compute Cloud (AWS EC2), or on a high-performance computing (HPC) cluster.</p>
    <fig position="float" id="btae114-F1">
      <label>Figure 1.</label>
      <caption>
        <p>Flow diagram of AutoGVP. (A) Required input files for custom or CAVATICA workflow. (B) Variant classification method decision tree. (C) Alluvial plot showing how InterVar classification changes in AutoGVP. The large numbers of concordant VUS (357 656), LB (20 374), and B (28 310) variants were removed for easier visualization. Numbers in parentheses represent the number of variants in that classification. Panels (A) and (B) created with BioRender.com.</p>
      </caption>
      <graphic xlink:href="btae114f1" position="float"/>
    </fig>
  </sec>
  <sec>
    <title>2 Methods</title>
    <sec>
      <title>2.1 Data input and preparation</title>
      <p>AutoGVP is implemented in R and bash and is run within the Docker image: <ext-link xlink:href="https://pgc-images.sbgenomics.com/diskin-lab/autogvp:v1.0.0" ext-link-type="uri">https://pgc-images.sbgenomics.com/diskin-lab/autogvp:v1.0.0</ext-link>. Detailed instructions on how to run AutoGVP are documented within the README of the GitHub repository. The script requires the following input files that must be supplied by the user: a VCF file with VEP annotations (*VEP.vcf), a multianno file generated by ANNOVAR run with “—vcfinput” flag (*hg38_multianno.txt), an InterVar output file (*multianno.txt.intervar), and an AutoPVS1 output file (*autopvs1.txt). Additionally, it requires a ClinVar VCF file (clinvar.vcf.gz), variant summary file (variant_summary.txt.gz), and submission summary file (submission_summary.txt.gz) which can be downloaded directly from the ClinVar FTP site (<ext-link xlink:href="https://ftp.ncbi.nlm.nih.gov/pub/clinvar/" ext-link-type="uri">https://ftp.ncbi.nlm.nih.gov/pub/clinvar/</ext-link>) or are stably provided through the “download_clinvar.sh” script (ClinVar 7/17/2023 database). Alternative archived ClinVar version database files can also be supplied by the user. The “select-clinVar-submissions.R” script generates a subset of the ClinVar database prior to running AutoGVP. Several arguments allow for customization of 1-star conflicting variant resolution. The “—conceptID_list” flag takes a user-defined MedGen Concept ID list and filters variant submissions for only those associated with provided Concept IDs. As a use case, we supplied Concept IDs associated with cancer, though IDs for any disease can be used to identify P/LP variants specifically linked to the disease of interest. When conflicts cannot be resolved through consensus, users can specify whether to resolve with a Concept ID list by taking the call of the most recent submission (“—latest”) or the most severe call (“—most_severe”). Prior to running variant annotation, AutoGVP will minimally filter for PASS variants as well as any user-provided filters added in the “—filter_criteria” argument (e.g. minimum variant depth, variant allele frequency). Example test files for each workflow are provided within the GitHub repository as well as in the <xref rid="sup1" ref-type="supplementary-material">Supplementary Files</xref>.</p>
    </sec>
    <sec>
      <title>2.2 Variant annotation and classification</title>
      <p>AutoGVP uses a hierarchical system to integrate ClinVar and InterVar variant annotations (<xref rid="btae114-F1" ref-type="fig">Fig. 1B</xref>). ClinVar variant classifications have different levels of review status represented by stars ranging from zero to four (<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/clinvar/docs/review_status/#revstat" ext-link-type="uri">https://www.ncbi.nlm.nih.gov/clinvar/docs/review_status/#revstat</ext-link>) (<xref rid="btae114-B7" ref-type="bibr">Rehm <italic toggle="yes">et al.</italic> 2015</xref>). AutoGVP retains the ClinVar classification for variants with two or more stars or 1-star with criteria provided by a single submitter. Variants that have 1-star with criteria provided, but have conflicting interpretations, are resolved through a multi-step decision tree with user-defined options. First, all variant submissions with “no assertion criteria provided” are excluded from the resolution process. In the absence of a Concept ID list, AutoGVP will initially try to resolve conflicts by determining a majority call and will otherwise take the call of the most recent submission. When a Concept ID list is supplied, submissions will be filtered for only those associated with provided Concept IDs, and AutoGVP will again search for a majority call. Otherwise, conflicts will be resolved by taking the call of the most recent submission by default or if the “—latest” argument is specified, will take the most severe call if “—most_severe” is specified, in which order of Pathogenic (P), Likely Pathogenic (LP), Variant of Uncertain Significance (VUS), Likely Benign (LB), Benign (B) (<xref rid="btae114-F1" ref-type="fig">Fig. 1B</xref>). Variants with zero stars and variants that have non-standard P/LP/VUS/LB/B calls in ClinVar (ie, “Affects|risk_factor”, “association_not_found”, etc.) are treated as no ClinVar classification.</p>
      <p>Variants unclassified by the ClinVar database undergo classification by InterVar, which was modified in the following two ways. First, since ClinGen recommends using the LOF PVS1 rule with varying modifications of strength (<xref rid="btae114-B1" ref-type="bibr">Abou Tayoun <italic toggle="yes">et al.</italic> 2018</xref>), we adjusted InterVar output using AutoPVS1 calls (<xref rid="btae114-B12" ref-type="bibr">Xiang <italic toggle="yes">et al.</italic> 2020</xref>). Second, since exclusion of the PP5/BP6 criterion is now recommended to prevent potential misuse and double counting (<xref rid="btae114-B1" ref-type="bibr">Abou Tayoun <italic toggle="yes">et al.</italic> 2018</xref>, <xref rid="btae114-B3" ref-type="bibr">Biesecker <italic toggle="yes">et al.</italic> 2018</xref>), we removed those two rules from InterVar. Furthermore, InterVar use ClinVar to interpret the PP5 rule, and as a result, may capture a P/LP classification from Online Mendelian Inheritance in Man (OMIM: <ext-link xlink:href="https://www.omim.org/" ext-link-type="uri">https://www.omim.org/</ext-link>) or GeneReviews (<xref rid="btae114-B2" ref-type="bibr">Adam <italic toggle="yes">et al.</italic> 2023</xref>) (zero stars) when in essence there is no indication of the specific variants in those two sources.</p>
      <p>In summary, AutoGVP will generate a final call to be one of P/LP/VUS/LB/B based on the integration of the ClinVar and modified InterVar calls described above. AutoGVP modifies the InterVar classification using corrected PVS1 strength and completely removes PP5/BP6, per the most recent guidance from ClinGen. Lastly, AutoGVP will annotate variants to a single gene transcript by selecting the transcript annotation provided in AutoPVS1 file. Additional gene and transcript annotations, when present, are retained in the output column “csq_vep”. The software saves two output files per run: an abridged file with minimal columns including coordinate, gene annotation, and pathogenicity assessment information, and a full output file containing additional annotation columns from the input VCF, ANNOVAR, InterVar, and AutoPVS1 files. The current pipeline was tested using data from dbGaP phs000720.v4.p1, VEP 104, InterVar v.2.2.1, AutoPVS1 v.2.0, ClinVar database 10/28/23, and AutoGVP v1.0.0.</p>
    </sec>
  </sec>
  <sec sec-type="results">
    <title>Results</title>
    <p>To evaluate AutoGVP performance, we annotated 413,585 rare germline variants (gnomAD v3.1.1 non-cancer &lt;0.001) from 121 individuals with rhabdomyosarcoma (dbGaP phs000720.v4.p1)(<xref rid="btae114-B4" ref-type="bibr">Kim <italic toggle="yes">et al.</italic> 2021</xref>) using HPC and CAVATICA. Computational time and usage to annotate the above file using Concept ID with “—latest” flag for HPC is as follows: total of 10 minutes with 0.33 CPU hours, and 36.2GB RAM. For CAVATICA a total of 9.1 min with 0.01 CPU hours, and 37.7GB RAM were needed. Final AutoGVP Classification of both HPC and CAVATICA were identical. AutoGVP annotations were compared to InterVar alone (<xref rid="sup1" ref-type="supplementary-material">Supplementary Table S1</xref>). While we focused our evaluation on P/LP variants given their direct relevance to disease, we note that AutoGVP resolved many InterVar VUS calls into P, LP, B, LB (<xref rid="btae114-F1" ref-type="fig">Fig. 1C</xref>). Using AutoGVP without the specification of the MedGen Concept ID, we identified 353 P variants and 310 LP variants (total: 663 P/LP variants). Applying Concept IDs associated with cancer, we identified the same 353 P variants when either the “—latest” or “—most_ severe” options were used, but 311 LP variants for ‘—most_severe’ and 310 LP variants for ‘—latest’. One <italic toggle="yes">MEN1</italic> variant (<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/clinvar/variation/305302/" ext-link-type="uri">https://www.ncbi.nlm.nih.gov/clinvar/variation/305302/</ext-link>) was classified as LP in “most severe” but classified as VUS using latest or omitting Concept IDs. In contrast, 353 P and 366 LP variants (total: 719 P/LP variants) were identified using InterVar only. Despite the 56-variant difference in total P/LP count between AutoGVP vs. InterVar, when comparing at the variant level across P/LP/VUS/LB/B classifications, a total of 6770 variants were discordant. A total of 112 variants were P/LP by AutoGVP, but VUS/LB/B by InterVar. All 112 variants were found in ClinVar: 35 variants with more than 2-stars and 77 1-star classifications. Of the 1-star classifications, 37 came from a single submitter and 40 had conflicting submissions, which were resolved using either “consensus” or the “most recent evaluated date”. Conversely, there were 168 variants P/LP by InterVar, but VUS/LB/B by AutoGVP. Of those 168 variants, 91 were classified by ClinVar and 77 were classified by InterVar. Of the InterVar-classified variants, 76 were downgraded by AutoGVP due to PVS1 adjustments, and one variant that still retained PVS1 = 1 was demoted to VUS due to removal of PP5, highlighting the over-calling of P/LP variants by InterVar alone. Furthermore, we evaluated common variants to understand how many would be assigned a P/LP classification. Of the 244,085 variants that have gnomAD population max allele frequency greater than 1%, 27 variants (0.01%) were annotated as P/LP by AutoGVP. Out of these 27 variants, only one variant was classified as P/LP by InterVar, and the remaining 26/27 variants (96.3%) were classified as P/LP by ClinVar with no AutoGVP adjustment (<xref rid="sup1" ref-type="supplementary-material">Supplementary Table S2</xref>).</p>
  </sec>
  <sec>
    <title>3 Discussion</title>
    <p>Currently available germline sequence variant classification tools are limited by (1) the number of variants that can be classified, (2) the ability to classify only previously reported variants, (3) the ACMG-AMP rules being modified after the time of tool development, (4) the lack of integration with ClinVar, the most extensive and curated germline variant database, and (5) paywall restrictions. Therefore, we developed AutoGVP, an open-source dockerized R workflow that automatically integrates ClinVar and modified InterVar variant annotations with updated ACMG-AMP criteria to classify the pathogenicity of germline sequence variants for research applications. It is important to note that the AutoGVP modifications of InterVar reported here do <italic toggle="yes">not</italic> incorporate gene-specific classification rules developed by ClinGen VCEP. Thus, review of variant classification for genes that have undergone the VCEP process is highly recommended. Furthermore, the use of AutoGVP should be limited to germline analysis at this time. As ClinVar adds submissions for somatic variants, we anticipate future enhancements of AutoGVP to enable classification of somatic variation. AutoGVP can be applied to disease-agnostic germline datasets in a fully automated fashion. With the increasing availability of germline exome and genome sequencing data, we anticipate AutoGVP will become a valuable resource for the research community.</p>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary Material</title>
    <supplementary-material id="sup1" position="float" content-type="local-data">
      <label>btae114_Supplementary_Data</label>
      <media xlink:href="btae114_supplementary_data.zip"/>
    </supplementary-material>
  </sec>
</body>
<back>
  <sec>
    <title>Supplementary data</title>
    <p><xref rid="sup1" ref-type="supplementary-material">Supplementary data</xref> are available at <italic toggle="yes">Bioinformatics</italic> online.</p>
  </sec>
  <sec sec-type="COI-statement">
    <title>Conflict of interest</title>
    <p>None declared.</p>
  </sec>
  <sec>
    <title>Funding</title>
    <p>This work has been supported by the National Institutes of Health [R03CA230366 to S.J.D., R01CA237562 to S.J.D., U2CHL138346 to A.C.R., and R03CA287169 to S.J.D. and J.L.R.], the Intramural Research program of the Division of Cancer Epidemiology and Genetics, National Cancer Institute, and the Division of Neurosurgery at the Children’s Hospital of Philadelphia. This work was also funded by Gabriella Miller Kids First pilot funds and in part, utilized the computational resources of the NIH HPC Biowulf cluster (<ext-link xlink:href="http://hpc.nih.gov" ext-link-type="uri">http://hpc.nih.gov</ext-link>).</p>
  </sec>
  <sec sec-type="data-availability">
    <title>Data availability</title>
    <p>The raw germline data used for this manuscript are available upon data access request to dbGAP under accession phs000720.v4.p1. De-identified test data from the dbGAP dataset used for this manuscript are available within the AutoGVP repository at <ext-link xlink:href="https://github.com/diskin-lab-chop/AutoGVP" ext-link-type="uri">https://github.com/diskin-lab-chop/AutoGVP</ext-link> and in the online supplementary material. Code and test data are archived at 10.5281/zenodo.10790815.</p>
  </sec>
  <ref-list id="ref1">
    <title>References</title>
    <ref id="btae114-B1">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Abou Tayoun</surname><given-names>AN</given-names></string-name>, <string-name><surname>Pesaran</surname><given-names>T</given-names></string-name>, <string-name><surname>DiStefano</surname><given-names>MT</given-names></string-name></person-group>, <etal>et al</etal><article-title>Recommendations for interpreting the loss of function PVS1 ACMG/AMP variant criterion</article-title>. <source>Hum. Mutat</source><year>2018</year>;<volume>39</volume>:<fpage>1517</fpage>–<lpage>24</lpage>.<pub-id pub-id-type="pmid">30192042</pub-id></mixed-citation>
    </ref>
    <ref id="btae114-B2">
      <mixed-citation publication-type="other"><person-group person-group-type="author"><string-name><surname>Adam</surname><given-names>MP</given-names></string-name></person-group><etal>et al</etal><year>2023</year>. GeneReviews<sup>®</sup> University of Washington, Seattle.</mixed-citation>
    </ref>
    <ref id="btae114-B3">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Biesecker</surname><given-names>LG</given-names></string-name>, <string-name><surname>Harrison</surname><given-names>SM</given-names></string-name></person-group>, <collab>ClinGen Sequence Variant Interpretation Working Group</collab>. <article-title>The ACMG/AMP reputable source criteria for the interpretation of sequence variants</article-title>. <source>Genet. Med</source><year>2018</year>;<volume>20</volume>:<fpage>1687</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="pmid">29543229</pub-id></mixed-citation>
    </ref>
    <ref id="btae114-B4">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kim</surname><given-names>J</given-names></string-name>, <string-name><surname>Light</surname><given-names>N</given-names></string-name>, <string-name><surname>Subasri</surname><given-names>V</given-names></string-name></person-group><etal>et al</etal><article-title>Pathogenic germline variants in cancer susceptibility genes in children and young adults with rhabdomyosarcoma</article-title>. <source>JCO Precis Oncol</source><year>2021</year>;<volume>5</volume>:PO.20.00218.</mixed-citation>
    </ref>
    <ref id="btae114-B5">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kopanos</surname><given-names>C</given-names></string-name>, <string-name><surname>Tsiolkas</surname><given-names>V</given-names></string-name>, <string-name><surname>Kouris</surname><given-names>A</given-names></string-name></person-group><etal>et al</etal><article-title>VarSome: the human genomic variant search engine</article-title>. <source>Bioinformatics</source><year>2019</year>;<volume>35</volume>:<fpage>1978</fpage>–<lpage>80</lpage>.<pub-id pub-id-type="pmid">30376034</pub-id></mixed-citation>
    </ref>
    <ref id="btae114-B6">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Li</surname><given-names>Q</given-names></string-name>, <string-name><surname>Wang</surname><given-names>K.</given-names></string-name></person-group><article-title>InterVar: clinical interpretation of genetic variants by the 2015 ACMG-AMP guidelines</article-title>. <source>Am J Hum Genet</source><year>2017</year>;<volume>100</volume>:<fpage>267</fpage>–<lpage>80</lpage>.<pub-id pub-id-type="pmid">28132688</pub-id></mixed-citation>
    </ref>
    <ref id="btae114-B7">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Rehm</surname><given-names>HL</given-names></string-name>, <string-name><surname>Berg</surname><given-names>JS</given-names></string-name>, <string-name><surname>Brooks</surname><given-names>LD</given-names></string-name></person-group>, <collab>ClinGen</collab><etal>et al</etal><article-title>ClinGen—the clinical genome resource</article-title>. <source>N. Engl. J. Med</source><year>2015</year>;<volume>372</volume>:<fpage>2235</fpage>–<lpage>42</lpage>.<pub-id pub-id-type="pmid">26014595</pub-id></mixed-citation>
    </ref>
    <ref id="btae114-B8">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Richards</surname><given-names>S</given-names></string-name>, <string-name><surname>Aziz</surname><given-names>N</given-names></string-name>, <string-name><surname>Bale</surname><given-names>S</given-names></string-name></person-group>, <etal>et al</etal><article-title>Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for molecular pathology</article-title>. <source>Genet. Med</source><year>2015</year>;<volume>17</volume>:<fpage>405</fpage>–<lpage>24</lpage>.<pub-id pub-id-type="pmid">25741868</pub-id></mixed-citation>
    </ref>
    <ref id="btae114-B9">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Scott</surname><given-names>AD</given-names></string-name>, <string-name><surname>Huang</surname><given-names>K-L</given-names></string-name>, <string-name><surname>Weerasinghe</surname><given-names>A</given-names></string-name></person-group><etal>et al</etal><article-title>CharGer: clinical characterization of germline variants</article-title>. <source>Bioinformatics</source><year>2019</year>;<volume>35</volume>:<fpage>865</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="pmid">30102335</pub-id></mixed-citation>
    </ref>
    <ref id="btae114-B10">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Singer-Berk</surname><given-names>M</given-names></string-name>, <string-name><surname>Gudmundsson</surname><given-names>S</given-names></string-name>, <string-name><surname>Baxter</surname><given-names>S</given-names></string-name></person-group><etal>et al</etal><article-title>Advanced variant classification framework reduces the false positive rate of predicted loss-of-function variants in population sequencing data</article-title>. <source>Am J Hum Genet</source><year>2023</year>;<volume>110</volume>:<fpage>1496</fpage>–<lpage>508</lpage>.<pub-id pub-id-type="pmid">37633279</pub-id></mixed-citation>
    </ref>
    <ref id="btae114-B11">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname><given-names>K</given-names></string-name>, <string-name><surname>Li</surname><given-names>M</given-names></string-name>, <string-name><surname>Hakonarson</surname><given-names>H</given-names></string-name></person-group><etal>et al</etal><article-title>ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data</article-title>. <source>Nucleic Acids Res</source><year>2010</year>;<volume>38</volume>:<fpage>e164</fpage>.<pub-id pub-id-type="pmid">20601685</pub-id></mixed-citation>
    </ref>
    <ref id="btae114-B12">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Xiang</surname><given-names>J</given-names></string-name>, <string-name><surname>Peng</surname><given-names>J</given-names></string-name>, <string-name><surname>Baxter</surname><given-names>S</given-names></string-name></person-group><etal>et al</etal><article-title>AutoPVS1: an automatic classification tool for PVS1 interpretation of null variants</article-title>. <source>Hum Mutat</source><year>2020</year>;<volume>41</volume>:<fpage>1488</fpage>–<lpage>98</lpage>.<pub-id pub-id-type="pmid">32442321</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.2?>
<?ConverterInfo.XSLTName jats2jats3.xsl?>
<?ConverterInfo.Version 1?>
<?properties open_access?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Bioinformatics</journal-id>
    <journal-id journal-id-type="iso-abbrev">Bioinformatics</journal-id>
    <journal-id journal-id-type="publisher-id">bioinformatics</journal-id>
    <journal-title-group>
      <journal-title>Bioinformatics</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">1367-4803</issn>
    <issn pub-type="epub">1367-4811</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">10955249</article-id>
    <article-id pub-id-type="pmid">38426335</article-id>
    <article-id pub-id-type="doi">10.1093/bioinformatics/btae114</article-id>
    <article-id pub-id-type="publisher-id">btae114</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Applications Note</subject>
        <subj-group subj-group-type="category-toc-heading">
          <subject>Genome Analysis</subject>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="category-taxonomy-collection">
        <subject>AcademicSubjects/SCI01060</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>AutoGVP: a dockerized workflow integrating ClinVar and InterVar germline sequence variant classification</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-6274-2841</contrib-id>
        <name>
          <surname>Kim</surname>
          <given-names>Jung</given-names>
        </name>
        <aff><institution>Division of Cancer Epidemiology and Genetics, National Cancer Institute</institution>, Rockville, MD 20850, <country country="US">United States</country></aff>
        <xref rid="btae114-FM1" ref-type="author-notes"/>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Naqvi</surname>
          <given-names>Ammar S</given-names>
        </name>
        <aff><institution>Center for Data-Driven Discovery in Biomedicine, Children’s Hospital of Philadelphia</institution>, Philadelphia, PA 19104, <country country="US">United States</country></aff>
        <aff><institution>Division of Neurosurgery, Children’s Hospital of Philadelphia</institution>, Philadelphia, PA 19104, <country country="US">United States</country></aff>
        <xref rid="btae114-FM1" ref-type="author-notes"/>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Corbett</surname>
          <given-names>Ryan J</given-names>
        </name>
        <aff><institution>Center for Data-Driven Discovery in Biomedicine, Children’s Hospital of Philadelphia</institution>, Philadelphia, PA 19104, <country country="US">United States</country></aff>
        <aff><institution>Division of Neurosurgery, Children’s Hospital of Philadelphia</institution>, Philadelphia, PA 19104, <country country="US">United States</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Kaufman</surname>
          <given-names>Rebecca S</given-names>
        </name>
        <aff><institution>Department of Bioinformatics and Health Informatics, Children’s Hospital of Philadelphia</institution>, Philadelphia, PA 19104, <country country="US">United States</country></aff>
        <aff><institution>Division of Oncology, Children's Hospital of Philadelphia</institution>, Philadelphia, PA 19104, <country country="US">United States</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Vaksman</surname>
          <given-names>Zalman</given-names>
        </name>
        <aff><institution>Department of Bioinformatics and Health Informatics, Children’s Hospital of Philadelphia</institution>, Philadelphia, PA 19104, <country country="US">United States</country></aff>
        <aff><institution>Division of Oncology, Children's Hospital of Philadelphia</institution>, Philadelphia, PA 19104, <country country="US">United States</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Brown</surname>
          <given-names>Miguel A</given-names>
        </name>
        <aff><institution>Center for Data-Driven Discovery in Biomedicine, Children’s Hospital of Philadelphia</institution>, Philadelphia, PA 19104, <country country="US">United States</country></aff>
        <aff><institution>Division of Neurosurgery, Children’s Hospital of Philadelphia</institution>, Philadelphia, PA 19104, <country country="US">United States</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Miller</surname>
          <given-names>Daniel P</given-names>
        </name>
        <aff><institution>Center for Data-Driven Discovery in Biomedicine, Children’s Hospital of Philadelphia</institution>, Philadelphia, PA 19104, <country country="US">United States</country></aff>
        <aff><institution>Division of Neurosurgery, Children’s Hospital of Philadelphia</institution>, Philadelphia, PA 19104, <country country="US">United States</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-2771-2572</contrib-id>
        <name>
          <surname>Phul</surname>
          <given-names>Saksham</given-names>
        </name>
        <aff><institution>Center for Data-Driven Discovery in Biomedicine, Children’s Hospital of Philadelphia</institution>, Philadelphia, PA 19104, <country country="US">United States</country></aff>
        <aff><institution>Division of Neurosurgery, Children’s Hospital of Philadelphia</institution>, Philadelphia, PA 19104, <country country="US">United States</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Geng</surname>
          <given-names>Zhuangzhuang</given-names>
        </name>
        <aff><institution>Center for Data-Driven Discovery in Biomedicine, Children’s Hospital of Philadelphia</institution>, Philadelphia, PA 19104, <country country="US">United States</country></aff>
        <aff><institution>Division of Neurosurgery, Children’s Hospital of Philadelphia</institution>, Philadelphia, PA 19104, <country country="US">United States</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Storm</surname>
          <given-names>Phillip B</given-names>
        </name>
        <aff><institution>Center for Data-Driven Discovery in Biomedicine, Children’s Hospital of Philadelphia</institution>, Philadelphia, PA 19104, <country country="US">United States</country></aff>
        <aff><institution>Division of Neurosurgery, Children’s Hospital of Philadelphia</institution>, Philadelphia, PA 19104, <country country="US">United States</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Resnick</surname>
          <given-names>Adam C</given-names>
        </name>
        <aff><institution>Center for Data-Driven Discovery in Biomedicine, Children’s Hospital of Philadelphia</institution>, Philadelphia, PA 19104, <country country="US">United States</country></aff>
        <aff><institution>Division of Neurosurgery, Children’s Hospital of Philadelphia</institution>, Philadelphia, PA 19104, <country country="US">United States</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Stewart</surname>
          <given-names>Douglas R</given-names>
        </name>
        <aff><institution>Division of Cancer Epidemiology and Genetics, National Cancer Institute</institution>, Rockville, MD 20850, <country country="US">United States</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-2171-3627</contrib-id>
        <name>
          <surname>Rokita</surname>
          <given-names>Jo Lynne</given-names>
        </name>
        <aff><institution>Center for Data-Driven Discovery in Biomedicine, Children’s Hospital of Philadelphia</institution>, Philadelphia, PA 19104, <country country="US">United States</country></aff>
        <aff><institution>Division of Neurosurgery, Children’s Hospital of Philadelphia</institution>, Philadelphia, PA 19104, <country country="US">United States</country></aff>
        <xref rid="btae114-FM2" ref-type="author-notes"/>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-7200-8939</contrib-id>
        <name>
          <surname>Diskin</surname>
          <given-names>Sharon J</given-names>
        </name>
        <aff><institution>Department of Bioinformatics and Health Informatics, Children’s Hospital of Philadelphia</institution>, Philadelphia, PA 19104, <country country="US">United States</country></aff>
        <aff><institution>Division of Oncology, Children's Hospital of Philadelphia</institution>, Philadelphia, PA 19104, <country country="US">United States</country></aff>
        <aff><institution>Department of Pediatrics, University of Pennsylvania</institution>, Philadelphia, PA 19104, <country country="US">United States</country></aff>
        <xref rid="btae114-FM2" ref-type="author-notes"/>
        <xref rid="btae114-cor1" ref-type="corresp"/>
        <!--diskin@chop.edu-->
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name>
          <surname>Alkan</surname>
          <given-names>Can</given-names>
        </name>
        <role>Associate Editor</role>
      </contrib>
    </contrib-group>
    <author-notes>
      <corresp id="btae114-cor1">Corresponding author. Sharon J. Diskin, Department of Bioinformatics and Health Informatics, 3026 Colket Translational Research Building, Center for Childhood Cancer Research, Children's Hospital of Philadelphia, PA 19104, United States. E-mail: <email>diskin@chop.edu</email></corresp>
      <fn id="btae114-FM1">
        <p>Jung Kim and Ammar S. Naqvi Equal contribution first authorship.</p>
      </fn>
      <fn id="btae114-FM2">
        <p>Jo Lynne Rokita and Sharon J. Diskin Equal senior contribution.</p>
      </fn>
    </author-notes>
    <pub-date pub-type="collection">
      <month>3</month>
      <year>2024</year>
    </pub-date>
    <pub-date pub-type="epub" iso-8601-date="2024-02-29">
      <day>29</day>
      <month>2</month>
      <year>2024</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>29</day>
      <month>2</month>
      <year>2024</year>
    </pub-date>
    <volume>40</volume>
    <issue>3</issue>
    <elocation-id>btae114</elocation-id>
    <history>
      <date date-type="received">
        <day>30</day>
        <month>11</month>
        <year>2023</year>
      </date>
      <date date-type="rev-recd">
        <day>09</day>
        <month>2</month>
        <year>2024</year>
      </date>
      <date date-type="editorial-decision">
        <day>19</day>
        <month>2</month>
        <year>2024</year>
      </date>
      <date date-type="accepted">
        <day>27</day>
        <month>2</month>
        <year>2024</year>
      </date>
      <date date-type="corrected-typeset">
        <day>20</day>
        <month>3</month>
        <year>2024</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2024. Published by Oxford University Press.</copyright-statement>
      <copyright-year>2024</copyright-year>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
      </license>
    </permissions>
    <self-uri xlink:href="btae114.pdf"/>
    <abstract>
      <title>Abstract</title>
      <sec id="s1">
        <title>Summary</title>
        <p>With the increasing rates of exome and whole genome sequencing, the ability to classify large sets of germline sequencing variants using up-to-date American College of Medical Genetics—Association for Molecular Pathology (ACMG-AMP) criteria is crucial. Here, we present Automated Germline Variant Pathogenicity (AutoGVP), a tool that integrates germline variant pathogenicity annotations from ClinVar and sequence variant classifications from a modified version of InterVar (PVS1 strength adjustments, removal of PP5/BP6). This tool facilitates large-scale, clinically focused classification of germline sequence variants in a research setting.</p>
      </sec>
      <sec id="s2">
        <title>Availability and implementation</title>
        <p>AutoGVP is an open source dockerized workflow implemented in R and freely available on GitHub at <ext-link xlink:href="https://github.com/diskin-lab-chop/AutoGVP" ext-link-type="uri">https://github.com/diskin-lab-chop/AutoGVP</ext-link>.</p>
      </sec>
    </abstract>
    <funding-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>National Institutes of Health</institution>
            <institution-id institution-id-type="DOI">10.13039/100000002</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>R03CA230366</award-id>
        <award-id>R01CA237562</award-id>
        <award-id>U2CHL138346</award-id>
        <award-id>R03CA287169</award-id>
      </award-group>
    </funding-group>
    <counts>
      <page-count count="4"/>
    </counts>
  </article-meta>
</front>
<body>
  <sec>
    <title>1 Introduction</title>
    <p>As exome and whole genome sequencing become more prevalent in clinical genetic testing and population-scale biobanks become more widely accessible, tools that facilitate classification of large sets of germline variants are crucial. Tools such as InterVar (<xref rid="btae114-B6" ref-type="bibr">Li and Wang 2017</xref>), CharGer (<xref rid="btae114-B9" ref-type="bibr">Scott <italic toggle="yes">et al.</italic> 2019</xref>), Franklin (<ext-link xlink:href="https://franklin.genoox.com" ext-link-type="uri">https://franklin.genoox.com</ext-link>), and Varsome (<xref rid="btae114-B5" ref-type="bibr">Kopanos <italic toggle="yes">et al.</italic> 2019</xref>) implement the ACMG-AMP guidelines for the interpretation of germline sequence variants (<xref rid="btae114-B8" ref-type="bibr">Richards <italic toggle="yes">et al.</italic> 2015</xref>). However, misclassification of variant pathogenicity may occur depending on the interpretation of specific ACMG-AMP criteria set by the tool at the time of the development. For example, variants can be mis-classified by applying “full strength” of the PVS1 rule (“a null variant in a gene where loss-of-function is a known mechanism of disease”), and/or use of the PP5 rule (“reputable source recently reports variant as pathogenic, but the evidence is not available to the laboratory to perform an independent evaluation”). In 2018, ACMG-AMP recommendations for PVS1 were modified so that null variants should not be considered at the same strength, but in different categories (PVS1, PVS1_Strong, PVS1_Moderate, PVS1_Supporting) (<xref rid="btae114-B1" ref-type="bibr">Abou Tayoun <italic toggle="yes">et al.</italic> 2018</xref>). To address the modified PVS1 rule, Xiang et al. developed AutoPVS1 to automate PVS1 adjustments (<xref rid="btae114-B1" ref-type="bibr">Abou Tayoun <italic toggle="yes">et al.</italic> 2018</xref>, <xref rid="btae114-B12" ref-type="bibr">Xiang <italic toggle="yes">et al.</italic> 2020</xref>). Furthermore, some tools are limited in the number of variants that can be classified at once or require the purchase of a license.</p>
    <p>InterVar reports each ACMG-AMP criterion with a score and each criterion is easily modifiable using open-source code accessible through GitHub. Concomitant with the development of these tools has been the dramatic increase in both the quantity and quality of germline variant classifications within the ClinVar database. This is due to the collaborative effort of ClinGen variant curation expert panels (<xref rid="btae114-B7" ref-type="bibr">Rehm <italic toggle="yes">et al.</italic> 2015</xref>) which meticulously refine, on a gene-specific basis, ACMG-AMP criteria using clinical (phenotype) information, the underlying biology of a gene (and structure of associated protein(s)), bioinformatics predictions and population genetics. It is important to note that (as of November 2023) InterVar does <italic toggle="yes">not</italic> automatically incorporate classification rules developed by ClinGen Variant Curation Expert Panels (VCEP; <ext-link xlink:href="https://clinicalgenome.org/affiliation/vcep/" ext-link-type="uri">https://clinicalgenome.org/affiliation/vcep/</ext-link>). In addition, ClinVar will only have variants that have been curated and deposited. There is a need for a comprehensive pipeline that not only annotates patient germline variation deposited to ClinVar, but also those not documented in ClinVar.</p>
    <p>We created the Automated Germline Variant Pathogenicity (AutoGVP) pipeline to classify germline variant pathogenicity in research settings through integrating both ClinVar and InterVar annotations. Uniquely, AutoGVP automatically modifies InterVar to classify variants using most current ACMG-AMP guidelines, by adjusting PVS1 strength (<xref rid="btae114-B7" ref-type="bibr">Rehm <italic toggle="yes">et al.</italic> 2015</xref>, <xref rid="btae114-B1" ref-type="bibr">Abou Tayoun <italic toggle="yes">et al.</italic> 2018</xref>), using autoPVS1 and removing the PP5 and BP6 rules (<xref rid="btae114-B3" ref-type="bibr">Biesecker <italic toggle="yes">et al.</italic> 2018</xref>). Adjusting PVS1 strength is crucial since InterVar can over-interpret loss-of-function (LOF) variants (<xref rid="btae114-B10" ref-type="bibr">Singer-Berk <italic toggle="yes">et al.</italic> 2023</xref>) as it classifies all LOF variants that are in LOF-intolerant genes curated by InterVar as PVS1 (<xref rid="btae114-B6" ref-type="bibr">Li and Wang 2017</xref>). AutoGVP can classify any number of variants in standard VCF format. The code is freely available as a dockerized workflow in GitHub (<ext-link xlink:href="https://github.com/diskin-lab-chop/AutoGVP" ext-link-type="uri">https://github.com/diskin-lab-chop/AutoGVP</ext-link>) with options of (1) supply a VEP-annotated VCF with ANNOVAR (<xref rid="btae114-B11" ref-type="bibr">Wang <italic toggle="yes">et al.</italic> 2010</xref>), AutoPVS1 (<xref rid="btae114-B12" ref-type="bibr">Xiang <italic toggle="yes">et al.</italic> 2020</xref>), and InterVar (<xref rid="btae114-B6" ref-type="bibr">Li and Wang 2017</xref>) outputs with the flexibility to update any of these and/or the provided ClinVar versions or (2) use similarly-annotated (ANNOVAR, InterVar, AutoPVS1, ClinVar) output from a cloud-based CAVATICA preprocessing workflow v.1.1.0 (<ext-link xlink:href="https://github.com/d3b-center/D3b-Pathogenicity-Preprocessing" ext-link-type="uri">https://github.com/d3b-center/D3b-Pathogenicity-Preprocessing</ext-link>) and public CAVATICA app (<ext-link xlink:href="https://cavatica.sbgenomics.com/public/apps/cavatica/apps-publisher/d3b-diskin-pathogenicity-preprocess-wf" ext-link-type="uri">https://cavatica.sbgenomics.com/public/apps/cavatica/apps-publisher/d3b-diskin-pathogenicity-preprocess-wf</ext-link>) on germline calls from the Kids First pipeline v.1.1.0 (<ext-link xlink:href="https://github.com/kids-first/kf-germline-workflow" ext-link-type="uri">https://github.com/kids-first/kf-germline-workflow</ext-link>) (<xref rid="btae114-F1" ref-type="fig">Fig. 1A</xref>). Depending on sample input size, AutoGVP can be run either locally, on Amazon Web Services Elastic Compute Cloud (AWS EC2), or on a high-performance computing (HPC) cluster.</p>
    <fig position="float" id="btae114-F1">
      <label>Figure 1.</label>
      <caption>
        <p>Flow diagram of AutoGVP. (A) Required input files for custom or CAVATICA workflow. (B) Variant classification method decision tree. (C) Alluvial plot showing how InterVar classification changes in AutoGVP. The large numbers of concordant VUS (357 656), LB (20 374), and B (28 310) variants were removed for easier visualization. Numbers in parentheses represent the number of variants in that classification. Panels (A) and (B) created with BioRender.com.</p>
      </caption>
      <graphic xlink:href="btae114f1" position="float"/>
    </fig>
  </sec>
  <sec>
    <title>2 Methods</title>
    <sec>
      <title>2.1 Data input and preparation</title>
      <p>AutoGVP is implemented in R and bash and is run within the Docker image: <ext-link xlink:href="https://pgc-images.sbgenomics.com/diskin-lab/autogvp:v1.0.0" ext-link-type="uri">https://pgc-images.sbgenomics.com/diskin-lab/autogvp:v1.0.0</ext-link>. Detailed instructions on how to run AutoGVP are documented within the README of the GitHub repository. The script requires the following input files that must be supplied by the user: a VCF file with VEP annotations (*VEP.vcf), a multianno file generated by ANNOVAR run with “—vcfinput” flag (*hg38_multianno.txt), an InterVar output file (*multianno.txt.intervar), and an AutoPVS1 output file (*autopvs1.txt). Additionally, it requires a ClinVar VCF file (clinvar.vcf.gz), variant summary file (variant_summary.txt.gz), and submission summary file (submission_summary.txt.gz) which can be downloaded directly from the ClinVar FTP site (<ext-link xlink:href="https://ftp.ncbi.nlm.nih.gov/pub/clinvar/" ext-link-type="uri">https://ftp.ncbi.nlm.nih.gov/pub/clinvar/</ext-link>) or are stably provided through the “download_clinvar.sh” script (ClinVar 7/17/2023 database). Alternative archived ClinVar version database files can also be supplied by the user. The “select-clinVar-submissions.R” script generates a subset of the ClinVar database prior to running AutoGVP. Several arguments allow for customization of 1-star conflicting variant resolution. The “—conceptID_list” flag takes a user-defined MedGen Concept ID list and filters variant submissions for only those associated with provided Concept IDs. As a use case, we supplied Concept IDs associated with cancer, though IDs for any disease can be used to identify P/LP variants specifically linked to the disease of interest. When conflicts cannot be resolved through consensus, users can specify whether to resolve with a Concept ID list by taking the call of the most recent submission (“—latest”) or the most severe call (“—most_severe”). Prior to running variant annotation, AutoGVP will minimally filter for PASS variants as well as any user-provided filters added in the “—filter_criteria” argument (e.g. minimum variant depth, variant allele frequency). Example test files for each workflow are provided within the GitHub repository as well as in the <xref rid="sup1" ref-type="supplementary-material">Supplementary Files</xref>.</p>
    </sec>
    <sec>
      <title>2.2 Variant annotation and classification</title>
      <p>AutoGVP uses a hierarchical system to integrate ClinVar and InterVar variant annotations (<xref rid="btae114-F1" ref-type="fig">Fig. 1B</xref>). ClinVar variant classifications have different levels of review status represented by stars ranging from zero to four (<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/clinvar/docs/review_status/#revstat" ext-link-type="uri">https://www.ncbi.nlm.nih.gov/clinvar/docs/review_status/#revstat</ext-link>) (<xref rid="btae114-B7" ref-type="bibr">Rehm <italic toggle="yes">et al.</italic> 2015</xref>). AutoGVP retains the ClinVar classification for variants with two or more stars or 1-star with criteria provided by a single submitter. Variants that have 1-star with criteria provided, but have conflicting interpretations, are resolved through a multi-step decision tree with user-defined options. First, all variant submissions with “no assertion criteria provided” are excluded from the resolution process. In the absence of a Concept ID list, AutoGVP will initially try to resolve conflicts by determining a majority call and will otherwise take the call of the most recent submission. When a Concept ID list is supplied, submissions will be filtered for only those associated with provided Concept IDs, and AutoGVP will again search for a majority call. Otherwise, conflicts will be resolved by taking the call of the most recent submission by default or if the “—latest” argument is specified, will take the most severe call if “—most_severe” is specified, in which order of Pathogenic (P), Likely Pathogenic (LP), Variant of Uncertain Significance (VUS), Likely Benign (LB), Benign (B) (<xref rid="btae114-F1" ref-type="fig">Fig. 1B</xref>). Variants with zero stars and variants that have non-standard P/LP/VUS/LB/B calls in ClinVar (ie, “Affects|risk_factor”, “association_not_found”, etc.) are treated as no ClinVar classification.</p>
      <p>Variants unclassified by the ClinVar database undergo classification by InterVar, which was modified in the following two ways. First, since ClinGen recommends using the LOF PVS1 rule with varying modifications of strength (<xref rid="btae114-B1" ref-type="bibr">Abou Tayoun <italic toggle="yes">et al.</italic> 2018</xref>), we adjusted InterVar output using AutoPVS1 calls (<xref rid="btae114-B12" ref-type="bibr">Xiang <italic toggle="yes">et al.</italic> 2020</xref>). Second, since exclusion of the PP5/BP6 criterion is now recommended to prevent potential misuse and double counting (<xref rid="btae114-B1" ref-type="bibr">Abou Tayoun <italic toggle="yes">et al.</italic> 2018</xref>, <xref rid="btae114-B3" ref-type="bibr">Biesecker <italic toggle="yes">et al.</italic> 2018</xref>), we removed those two rules from InterVar. Furthermore, InterVar use ClinVar to interpret the PP5 rule, and as a result, may capture a P/LP classification from Online Mendelian Inheritance in Man (OMIM: <ext-link xlink:href="https://www.omim.org/" ext-link-type="uri">https://www.omim.org/</ext-link>) or GeneReviews (<xref rid="btae114-B2" ref-type="bibr">Adam <italic toggle="yes">et al.</italic> 2023</xref>) (zero stars) when in essence there is no indication of the specific variants in those two sources.</p>
      <p>In summary, AutoGVP will generate a final call to be one of P/LP/VUS/LB/B based on the integration of the ClinVar and modified InterVar calls described above. AutoGVP modifies the InterVar classification using corrected PVS1 strength and completely removes PP5/BP6, per the most recent guidance from ClinGen. Lastly, AutoGVP will annotate variants to a single gene transcript by selecting the transcript annotation provided in AutoPVS1 file. Additional gene and transcript annotations, when present, are retained in the output column “csq_vep”. The software saves two output files per run: an abridged file with minimal columns including coordinate, gene annotation, and pathogenicity assessment information, and a full output file containing additional annotation columns from the input VCF, ANNOVAR, InterVar, and AutoPVS1 files. The current pipeline was tested using data from dbGaP phs000720.v4.p1, VEP 104, InterVar v.2.2.1, AutoPVS1 v.2.0, ClinVar database 10/28/23, and AutoGVP v1.0.0.</p>
    </sec>
  </sec>
  <sec sec-type="results">
    <title>Results</title>
    <p>To evaluate AutoGVP performance, we annotated 413,585 rare germline variants (gnomAD v3.1.1 non-cancer &lt;0.001) from 121 individuals with rhabdomyosarcoma (dbGaP phs000720.v4.p1)(<xref rid="btae114-B4" ref-type="bibr">Kim <italic toggle="yes">et al.</italic> 2021</xref>) using HPC and CAVATICA. Computational time and usage to annotate the above file using Concept ID with “—latest” flag for HPC is as follows: total of 10 minutes with 0.33 CPU hours, and 36.2GB RAM. For CAVATICA a total of 9.1 min with 0.01 CPU hours, and 37.7GB RAM were needed. Final AutoGVP Classification of both HPC and CAVATICA were identical. AutoGVP annotations were compared to InterVar alone (<xref rid="sup1" ref-type="supplementary-material">Supplementary Table S1</xref>). While we focused our evaluation on P/LP variants given their direct relevance to disease, we note that AutoGVP resolved many InterVar VUS calls into P, LP, B, LB (<xref rid="btae114-F1" ref-type="fig">Fig. 1C</xref>). Using AutoGVP without the specification of the MedGen Concept ID, we identified 353 P variants and 310 LP variants (total: 663 P/LP variants). Applying Concept IDs associated with cancer, we identified the same 353 P variants when either the “—latest” or “—most_ severe” options were used, but 311 LP variants for ‘—most_severe’ and 310 LP variants for ‘—latest’. One <italic toggle="yes">MEN1</italic> variant (<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/clinvar/variation/305302/" ext-link-type="uri">https://www.ncbi.nlm.nih.gov/clinvar/variation/305302/</ext-link>) was classified as LP in “most severe” but classified as VUS using latest or omitting Concept IDs. In contrast, 353 P and 366 LP variants (total: 719 P/LP variants) were identified using InterVar only. Despite the 56-variant difference in total P/LP count between AutoGVP vs. InterVar, when comparing at the variant level across P/LP/VUS/LB/B classifications, a total of 6770 variants were discordant. A total of 112 variants were P/LP by AutoGVP, but VUS/LB/B by InterVar. All 112 variants were found in ClinVar: 35 variants with more than 2-stars and 77 1-star classifications. Of the 1-star classifications, 37 came from a single submitter and 40 had conflicting submissions, which were resolved using either “consensus” or the “most recent evaluated date”. Conversely, there were 168 variants P/LP by InterVar, but VUS/LB/B by AutoGVP. Of those 168 variants, 91 were classified by ClinVar and 77 were classified by InterVar. Of the InterVar-classified variants, 76 were downgraded by AutoGVP due to PVS1 adjustments, and one variant that still retained PVS1 = 1 was demoted to VUS due to removal of PP5, highlighting the over-calling of P/LP variants by InterVar alone. Furthermore, we evaluated common variants to understand how many would be assigned a P/LP classification. Of the 244,085 variants that have gnomAD population max allele frequency greater than 1%, 27 variants (0.01%) were annotated as P/LP by AutoGVP. Out of these 27 variants, only one variant was classified as P/LP by InterVar, and the remaining 26/27 variants (96.3%) were classified as P/LP by ClinVar with no AutoGVP adjustment (<xref rid="sup1" ref-type="supplementary-material">Supplementary Table S2</xref>).</p>
  </sec>
  <sec>
    <title>3 Discussion</title>
    <p>Currently available germline sequence variant classification tools are limited by (1) the number of variants that can be classified, (2) the ability to classify only previously reported variants, (3) the ACMG-AMP rules being modified after the time of tool development, (4) the lack of integration with ClinVar, the most extensive and curated germline variant database, and (5) paywall restrictions. Therefore, we developed AutoGVP, an open-source dockerized R workflow that automatically integrates ClinVar and modified InterVar variant annotations with updated ACMG-AMP criteria to classify the pathogenicity of germline sequence variants for research applications. It is important to note that the AutoGVP modifications of InterVar reported here do <italic toggle="yes">not</italic> incorporate gene-specific classification rules developed by ClinGen VCEP. Thus, review of variant classification for genes that have undergone the VCEP process is highly recommended. Furthermore, the use of AutoGVP should be limited to germline analysis at this time. As ClinVar adds submissions for somatic variants, we anticipate future enhancements of AutoGVP to enable classification of somatic variation. AutoGVP can be applied to disease-agnostic germline datasets in a fully automated fashion. With the increasing availability of germline exome and genome sequencing data, we anticipate AutoGVP will become a valuable resource for the research community.</p>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary Material</title>
    <supplementary-material id="sup1" position="float" content-type="local-data">
      <label>btae114_Supplementary_Data</label>
      <media xlink:href="btae114_supplementary_data.zip"/>
    </supplementary-material>
  </sec>
</body>
<back>
  <sec>
    <title>Supplementary data</title>
    <p><xref rid="sup1" ref-type="supplementary-material">Supplementary data</xref> are available at <italic toggle="yes">Bioinformatics</italic> online.</p>
  </sec>
  <sec sec-type="COI-statement">
    <title>Conflict of interest</title>
    <p>None declared.</p>
  </sec>
  <sec>
    <title>Funding</title>
    <p>This work has been supported by the National Institutes of Health [R03CA230366 to S.J.D., R01CA237562 to S.J.D., U2CHL138346 to A.C.R., and R03CA287169 to S.J.D. and J.L.R.], the Intramural Research program of the Division of Cancer Epidemiology and Genetics, National Cancer Institute, and the Division of Neurosurgery at the Children’s Hospital of Philadelphia. This work was also funded by Gabriella Miller Kids First pilot funds and in part, utilized the computational resources of the NIH HPC Biowulf cluster (<ext-link xlink:href="http://hpc.nih.gov" ext-link-type="uri">http://hpc.nih.gov</ext-link>).</p>
  </sec>
  <sec sec-type="data-availability">
    <title>Data availability</title>
    <p>The raw germline data used for this manuscript are available upon data access request to dbGAP under accession phs000720.v4.p1. De-identified test data from the dbGAP dataset used for this manuscript are available within the AutoGVP repository at <ext-link xlink:href="https://github.com/diskin-lab-chop/AutoGVP" ext-link-type="uri">https://github.com/diskin-lab-chop/AutoGVP</ext-link> and in the online supplementary material. Code and test data are archived at 10.5281/zenodo.10790815.</p>
  </sec>
  <ref-list id="ref1">
    <title>References</title>
    <ref id="btae114-B1">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Abou Tayoun</surname><given-names>AN</given-names></string-name>, <string-name><surname>Pesaran</surname><given-names>T</given-names></string-name>, <string-name><surname>DiStefano</surname><given-names>MT</given-names></string-name></person-group>, <etal>et al</etal><article-title>Recommendations for interpreting the loss of function PVS1 ACMG/AMP variant criterion</article-title>. <source>Hum. Mutat</source><year>2018</year>;<volume>39</volume>:<fpage>1517</fpage>–<lpage>24</lpage>.<pub-id pub-id-type="pmid">30192042</pub-id></mixed-citation>
    </ref>
    <ref id="btae114-B2">
      <mixed-citation publication-type="other"><person-group person-group-type="author"><string-name><surname>Adam</surname><given-names>MP</given-names></string-name></person-group><etal>et al</etal><year>2023</year>. GeneReviews<sup>®</sup> University of Washington, Seattle.</mixed-citation>
    </ref>
    <ref id="btae114-B3">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Biesecker</surname><given-names>LG</given-names></string-name>, <string-name><surname>Harrison</surname><given-names>SM</given-names></string-name></person-group>, <collab>ClinGen Sequence Variant Interpretation Working Group</collab>. <article-title>The ACMG/AMP reputable source criteria for the interpretation of sequence variants</article-title>. <source>Genet. Med</source><year>2018</year>;<volume>20</volume>:<fpage>1687</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="pmid">29543229</pub-id></mixed-citation>
    </ref>
    <ref id="btae114-B4">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kim</surname><given-names>J</given-names></string-name>, <string-name><surname>Light</surname><given-names>N</given-names></string-name>, <string-name><surname>Subasri</surname><given-names>V</given-names></string-name></person-group><etal>et al</etal><article-title>Pathogenic germline variants in cancer susceptibility genes in children and young adults with rhabdomyosarcoma</article-title>. <source>JCO Precis Oncol</source><year>2021</year>;<volume>5</volume>:PO.20.00218.</mixed-citation>
    </ref>
    <ref id="btae114-B5">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kopanos</surname><given-names>C</given-names></string-name>, <string-name><surname>Tsiolkas</surname><given-names>V</given-names></string-name>, <string-name><surname>Kouris</surname><given-names>A</given-names></string-name></person-group><etal>et al</etal><article-title>VarSome: the human genomic variant search engine</article-title>. <source>Bioinformatics</source><year>2019</year>;<volume>35</volume>:<fpage>1978</fpage>–<lpage>80</lpage>.<pub-id pub-id-type="pmid">30376034</pub-id></mixed-citation>
    </ref>
    <ref id="btae114-B6">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Li</surname><given-names>Q</given-names></string-name>, <string-name><surname>Wang</surname><given-names>K.</given-names></string-name></person-group><article-title>InterVar: clinical interpretation of genetic variants by the 2015 ACMG-AMP guidelines</article-title>. <source>Am J Hum Genet</source><year>2017</year>;<volume>100</volume>:<fpage>267</fpage>–<lpage>80</lpage>.<pub-id pub-id-type="pmid">28132688</pub-id></mixed-citation>
    </ref>
    <ref id="btae114-B7">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Rehm</surname><given-names>HL</given-names></string-name>, <string-name><surname>Berg</surname><given-names>JS</given-names></string-name>, <string-name><surname>Brooks</surname><given-names>LD</given-names></string-name></person-group>, <collab>ClinGen</collab><etal>et al</etal><article-title>ClinGen—the clinical genome resource</article-title>. <source>N. Engl. J. Med</source><year>2015</year>;<volume>372</volume>:<fpage>2235</fpage>–<lpage>42</lpage>.<pub-id pub-id-type="pmid">26014595</pub-id></mixed-citation>
    </ref>
    <ref id="btae114-B8">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Richards</surname><given-names>S</given-names></string-name>, <string-name><surname>Aziz</surname><given-names>N</given-names></string-name>, <string-name><surname>Bale</surname><given-names>S</given-names></string-name></person-group>, <etal>et al</etal><article-title>Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for molecular pathology</article-title>. <source>Genet. Med</source><year>2015</year>;<volume>17</volume>:<fpage>405</fpage>–<lpage>24</lpage>.<pub-id pub-id-type="pmid">25741868</pub-id></mixed-citation>
    </ref>
    <ref id="btae114-B9">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Scott</surname><given-names>AD</given-names></string-name>, <string-name><surname>Huang</surname><given-names>K-L</given-names></string-name>, <string-name><surname>Weerasinghe</surname><given-names>A</given-names></string-name></person-group><etal>et al</etal><article-title>CharGer: clinical characterization of germline variants</article-title>. <source>Bioinformatics</source><year>2019</year>;<volume>35</volume>:<fpage>865</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="pmid">30102335</pub-id></mixed-citation>
    </ref>
    <ref id="btae114-B10">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Singer-Berk</surname><given-names>M</given-names></string-name>, <string-name><surname>Gudmundsson</surname><given-names>S</given-names></string-name>, <string-name><surname>Baxter</surname><given-names>S</given-names></string-name></person-group><etal>et al</etal><article-title>Advanced variant classification framework reduces the false positive rate of predicted loss-of-function variants in population sequencing data</article-title>. <source>Am J Hum Genet</source><year>2023</year>;<volume>110</volume>:<fpage>1496</fpage>–<lpage>508</lpage>.<pub-id pub-id-type="pmid">37633279</pub-id></mixed-citation>
    </ref>
    <ref id="btae114-B11">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname><given-names>K</given-names></string-name>, <string-name><surname>Li</surname><given-names>M</given-names></string-name>, <string-name><surname>Hakonarson</surname><given-names>H</given-names></string-name></person-group><etal>et al</etal><article-title>ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data</article-title>. <source>Nucleic Acids Res</source><year>2010</year>;<volume>38</volume>:<fpage>e164</fpage>.<pub-id pub-id-type="pmid">20601685</pub-id></mixed-citation>
    </ref>
    <ref id="btae114-B12">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Xiang</surname><given-names>J</given-names></string-name>, <string-name><surname>Peng</surname><given-names>J</given-names></string-name>, <string-name><surname>Baxter</surname><given-names>S</given-names></string-name></person-group><etal>et al</etal><article-title>AutoPVS1: an automatic classification tool for PVS1 interpretation of null variants</article-title>. <source>Hum Mutat</source><year>2020</year>;<volume>41</volume>:<fpage>1488</fpage>–<lpage>98</lpage>.<pub-id pub-id-type="pmid">32442321</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.2?>
<?ConverterInfo.XSLTName jats2jats3.xsl?>
<?ConverterInfo.Version 1?>
<?properties open_access?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Bioinformatics</journal-id>
    <journal-id journal-id-type="iso-abbrev">Bioinformatics</journal-id>
    <journal-id journal-id-type="publisher-id">bioinformatics</journal-id>
    <journal-title-group>
      <journal-title>Bioinformatics</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">1367-4803</issn>
    <issn pub-type="epub">1367-4811</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">10955249</article-id>
    <article-id pub-id-type="pmid">38426335</article-id>
    <article-id pub-id-type="doi">10.1093/bioinformatics/btae114</article-id>
    <article-id pub-id-type="publisher-id">btae114</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Applications Note</subject>
        <subj-group subj-group-type="category-toc-heading">
          <subject>Genome Analysis</subject>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="category-taxonomy-collection">
        <subject>AcademicSubjects/SCI01060</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>AutoGVP: a dockerized workflow integrating ClinVar and InterVar germline sequence variant classification</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-6274-2841</contrib-id>
        <name>
          <surname>Kim</surname>
          <given-names>Jung</given-names>
        </name>
        <aff><institution>Division of Cancer Epidemiology and Genetics, National Cancer Institute</institution>, Rockville, MD 20850, <country country="US">United States</country></aff>
        <xref rid="btae114-FM1" ref-type="author-notes"/>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Naqvi</surname>
          <given-names>Ammar S</given-names>
        </name>
        <aff><institution>Center for Data-Driven Discovery in Biomedicine, Children’s Hospital of Philadelphia</institution>, Philadelphia, PA 19104, <country country="US">United States</country></aff>
        <aff><institution>Division of Neurosurgery, Children’s Hospital of Philadelphia</institution>, Philadelphia, PA 19104, <country country="US">United States</country></aff>
        <xref rid="btae114-FM1" ref-type="author-notes"/>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Corbett</surname>
          <given-names>Ryan J</given-names>
        </name>
        <aff><institution>Center for Data-Driven Discovery in Biomedicine, Children’s Hospital of Philadelphia</institution>, Philadelphia, PA 19104, <country country="US">United States</country></aff>
        <aff><institution>Division of Neurosurgery, Children’s Hospital of Philadelphia</institution>, Philadelphia, PA 19104, <country country="US">United States</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Kaufman</surname>
          <given-names>Rebecca S</given-names>
        </name>
        <aff><institution>Department of Bioinformatics and Health Informatics, Children’s Hospital of Philadelphia</institution>, Philadelphia, PA 19104, <country country="US">United States</country></aff>
        <aff><institution>Division of Oncology, Children's Hospital of Philadelphia</institution>, Philadelphia, PA 19104, <country country="US">United States</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Vaksman</surname>
          <given-names>Zalman</given-names>
        </name>
        <aff><institution>Department of Bioinformatics and Health Informatics, Children’s Hospital of Philadelphia</institution>, Philadelphia, PA 19104, <country country="US">United States</country></aff>
        <aff><institution>Division of Oncology, Children's Hospital of Philadelphia</institution>, Philadelphia, PA 19104, <country country="US">United States</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Brown</surname>
          <given-names>Miguel A</given-names>
        </name>
        <aff><institution>Center for Data-Driven Discovery in Biomedicine, Children’s Hospital of Philadelphia</institution>, Philadelphia, PA 19104, <country country="US">United States</country></aff>
        <aff><institution>Division of Neurosurgery, Children’s Hospital of Philadelphia</institution>, Philadelphia, PA 19104, <country country="US">United States</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Miller</surname>
          <given-names>Daniel P</given-names>
        </name>
        <aff><institution>Center for Data-Driven Discovery in Biomedicine, Children’s Hospital of Philadelphia</institution>, Philadelphia, PA 19104, <country country="US">United States</country></aff>
        <aff><institution>Division of Neurosurgery, Children’s Hospital of Philadelphia</institution>, Philadelphia, PA 19104, <country country="US">United States</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-2771-2572</contrib-id>
        <name>
          <surname>Phul</surname>
          <given-names>Saksham</given-names>
        </name>
        <aff><institution>Center for Data-Driven Discovery in Biomedicine, Children’s Hospital of Philadelphia</institution>, Philadelphia, PA 19104, <country country="US">United States</country></aff>
        <aff><institution>Division of Neurosurgery, Children’s Hospital of Philadelphia</institution>, Philadelphia, PA 19104, <country country="US">United States</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Geng</surname>
          <given-names>Zhuangzhuang</given-names>
        </name>
        <aff><institution>Center for Data-Driven Discovery in Biomedicine, Children’s Hospital of Philadelphia</institution>, Philadelphia, PA 19104, <country country="US">United States</country></aff>
        <aff><institution>Division of Neurosurgery, Children’s Hospital of Philadelphia</institution>, Philadelphia, PA 19104, <country country="US">United States</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Storm</surname>
          <given-names>Phillip B</given-names>
        </name>
        <aff><institution>Center for Data-Driven Discovery in Biomedicine, Children’s Hospital of Philadelphia</institution>, Philadelphia, PA 19104, <country country="US">United States</country></aff>
        <aff><institution>Division of Neurosurgery, Children’s Hospital of Philadelphia</institution>, Philadelphia, PA 19104, <country country="US">United States</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Resnick</surname>
          <given-names>Adam C</given-names>
        </name>
        <aff><institution>Center for Data-Driven Discovery in Biomedicine, Children’s Hospital of Philadelphia</institution>, Philadelphia, PA 19104, <country country="US">United States</country></aff>
        <aff><institution>Division of Neurosurgery, Children’s Hospital of Philadelphia</institution>, Philadelphia, PA 19104, <country country="US">United States</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Stewart</surname>
          <given-names>Douglas R</given-names>
        </name>
        <aff><institution>Division of Cancer Epidemiology and Genetics, National Cancer Institute</institution>, Rockville, MD 20850, <country country="US">United States</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-2171-3627</contrib-id>
        <name>
          <surname>Rokita</surname>
          <given-names>Jo Lynne</given-names>
        </name>
        <aff><institution>Center for Data-Driven Discovery in Biomedicine, Children’s Hospital of Philadelphia</institution>, Philadelphia, PA 19104, <country country="US">United States</country></aff>
        <aff><institution>Division of Neurosurgery, Children’s Hospital of Philadelphia</institution>, Philadelphia, PA 19104, <country country="US">United States</country></aff>
        <xref rid="btae114-FM2" ref-type="author-notes"/>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-7200-8939</contrib-id>
        <name>
          <surname>Diskin</surname>
          <given-names>Sharon J</given-names>
        </name>
        <aff><institution>Department of Bioinformatics and Health Informatics, Children’s Hospital of Philadelphia</institution>, Philadelphia, PA 19104, <country country="US">United States</country></aff>
        <aff><institution>Division of Oncology, Children's Hospital of Philadelphia</institution>, Philadelphia, PA 19104, <country country="US">United States</country></aff>
        <aff><institution>Department of Pediatrics, University of Pennsylvania</institution>, Philadelphia, PA 19104, <country country="US">United States</country></aff>
        <xref rid="btae114-FM2" ref-type="author-notes"/>
        <xref rid="btae114-cor1" ref-type="corresp"/>
        <!--diskin@chop.edu-->
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name>
          <surname>Alkan</surname>
          <given-names>Can</given-names>
        </name>
        <role>Associate Editor</role>
      </contrib>
    </contrib-group>
    <author-notes>
      <corresp id="btae114-cor1">Corresponding author. Sharon J. Diskin, Department of Bioinformatics and Health Informatics, 3026 Colket Translational Research Building, Center for Childhood Cancer Research, Children's Hospital of Philadelphia, PA 19104, United States. E-mail: <email>diskin@chop.edu</email></corresp>
      <fn id="btae114-FM1">
        <p>Jung Kim and Ammar S. Naqvi Equal contribution first authorship.</p>
      </fn>
      <fn id="btae114-FM2">
        <p>Jo Lynne Rokita and Sharon J. Diskin Equal senior contribution.</p>
      </fn>
    </author-notes>
    <pub-date pub-type="collection">
      <month>3</month>
      <year>2024</year>
    </pub-date>
    <pub-date pub-type="epub" iso-8601-date="2024-02-29">
      <day>29</day>
      <month>2</month>
      <year>2024</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>29</day>
      <month>2</month>
      <year>2024</year>
    </pub-date>
    <volume>40</volume>
    <issue>3</issue>
    <elocation-id>btae114</elocation-id>
    <history>
      <date date-type="received">
        <day>30</day>
        <month>11</month>
        <year>2023</year>
      </date>
      <date date-type="rev-recd">
        <day>09</day>
        <month>2</month>
        <year>2024</year>
      </date>
      <date date-type="editorial-decision">
        <day>19</day>
        <month>2</month>
        <year>2024</year>
      </date>
      <date date-type="accepted">
        <day>27</day>
        <month>2</month>
        <year>2024</year>
      </date>
      <date date-type="corrected-typeset">
        <day>20</day>
        <month>3</month>
        <year>2024</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2024. Published by Oxford University Press.</copyright-statement>
      <copyright-year>2024</copyright-year>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
      </license>
    </permissions>
    <self-uri xlink:href="btae114.pdf"/>
    <abstract>
      <title>Abstract</title>
      <sec id="s1">
        <title>Summary</title>
        <p>With the increasing rates of exome and whole genome sequencing, the ability to classify large sets of germline sequencing variants using up-to-date American College of Medical Genetics—Association for Molecular Pathology (ACMG-AMP) criteria is crucial. Here, we present Automated Germline Variant Pathogenicity (AutoGVP), a tool that integrates germline variant pathogenicity annotations from ClinVar and sequence variant classifications from a modified version of InterVar (PVS1 strength adjustments, removal of PP5/BP6). This tool facilitates large-scale, clinically focused classification of germline sequence variants in a research setting.</p>
      </sec>
      <sec id="s2">
        <title>Availability and implementation</title>
        <p>AutoGVP is an open source dockerized workflow implemented in R and freely available on GitHub at <ext-link xlink:href="https://github.com/diskin-lab-chop/AutoGVP" ext-link-type="uri">https://github.com/diskin-lab-chop/AutoGVP</ext-link>.</p>
      </sec>
    </abstract>
    <funding-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>National Institutes of Health</institution>
            <institution-id institution-id-type="DOI">10.13039/100000002</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>R03CA230366</award-id>
        <award-id>R01CA237562</award-id>
        <award-id>U2CHL138346</award-id>
        <award-id>R03CA287169</award-id>
      </award-group>
    </funding-group>
    <counts>
      <page-count count="4"/>
    </counts>
  </article-meta>
</front>
<body>
  <sec>
    <title>1 Introduction</title>
    <p>As exome and whole genome sequencing become more prevalent in clinical genetic testing and population-scale biobanks become more widely accessible, tools that facilitate classification of large sets of germline variants are crucial. Tools such as InterVar (<xref rid="btae114-B6" ref-type="bibr">Li and Wang 2017</xref>), CharGer (<xref rid="btae114-B9" ref-type="bibr">Scott <italic toggle="yes">et al.</italic> 2019</xref>), Franklin (<ext-link xlink:href="https://franklin.genoox.com" ext-link-type="uri">https://franklin.genoox.com</ext-link>), and Varsome (<xref rid="btae114-B5" ref-type="bibr">Kopanos <italic toggle="yes">et al.</italic> 2019</xref>) implement the ACMG-AMP guidelines for the interpretation of germline sequence variants (<xref rid="btae114-B8" ref-type="bibr">Richards <italic toggle="yes">et al.</italic> 2015</xref>). However, misclassification of variant pathogenicity may occur depending on the interpretation of specific ACMG-AMP criteria set by the tool at the time of the development. For example, variants can be mis-classified by applying “full strength” of the PVS1 rule (“a null variant in a gene where loss-of-function is a known mechanism of disease”), and/or use of the PP5 rule (“reputable source recently reports variant as pathogenic, but the evidence is not available to the laboratory to perform an independent evaluation”). In 2018, ACMG-AMP recommendations for PVS1 were modified so that null variants should not be considered at the same strength, but in different categories (PVS1, PVS1_Strong, PVS1_Moderate, PVS1_Supporting) (<xref rid="btae114-B1" ref-type="bibr">Abou Tayoun <italic toggle="yes">et al.</italic> 2018</xref>). To address the modified PVS1 rule, Xiang et al. developed AutoPVS1 to automate PVS1 adjustments (<xref rid="btae114-B1" ref-type="bibr">Abou Tayoun <italic toggle="yes">et al.</italic> 2018</xref>, <xref rid="btae114-B12" ref-type="bibr">Xiang <italic toggle="yes">et al.</italic> 2020</xref>). Furthermore, some tools are limited in the number of variants that can be classified at once or require the purchase of a license.</p>
    <p>InterVar reports each ACMG-AMP criterion with a score and each criterion is easily modifiable using open-source code accessible through GitHub. Concomitant with the development of these tools has been the dramatic increase in both the quantity and quality of germline variant classifications within the ClinVar database. This is due to the collaborative effort of ClinGen variant curation expert panels (<xref rid="btae114-B7" ref-type="bibr">Rehm <italic toggle="yes">et al.</italic> 2015</xref>) which meticulously refine, on a gene-specific basis, ACMG-AMP criteria using clinical (phenotype) information, the underlying biology of a gene (and structure of associated protein(s)), bioinformatics predictions and population genetics. It is important to note that (as of November 2023) InterVar does <italic toggle="yes">not</italic> automatically incorporate classification rules developed by ClinGen Variant Curation Expert Panels (VCEP; <ext-link xlink:href="https://clinicalgenome.org/affiliation/vcep/" ext-link-type="uri">https://clinicalgenome.org/affiliation/vcep/</ext-link>). In addition, ClinVar will only have variants that have been curated and deposited. There is a need for a comprehensive pipeline that not only annotates patient germline variation deposited to ClinVar, but also those not documented in ClinVar.</p>
    <p>We created the Automated Germline Variant Pathogenicity (AutoGVP) pipeline to classify germline variant pathogenicity in research settings through integrating both ClinVar and InterVar annotations. Uniquely, AutoGVP automatically modifies InterVar to classify variants using most current ACMG-AMP guidelines, by adjusting PVS1 strength (<xref rid="btae114-B7" ref-type="bibr">Rehm <italic toggle="yes">et al.</italic> 2015</xref>, <xref rid="btae114-B1" ref-type="bibr">Abou Tayoun <italic toggle="yes">et al.</italic> 2018</xref>), using autoPVS1 and removing the PP5 and BP6 rules (<xref rid="btae114-B3" ref-type="bibr">Biesecker <italic toggle="yes">et al.</italic> 2018</xref>). Adjusting PVS1 strength is crucial since InterVar can over-interpret loss-of-function (LOF) variants (<xref rid="btae114-B10" ref-type="bibr">Singer-Berk <italic toggle="yes">et al.</italic> 2023</xref>) as it classifies all LOF variants that are in LOF-intolerant genes curated by InterVar as PVS1 (<xref rid="btae114-B6" ref-type="bibr">Li and Wang 2017</xref>). AutoGVP can classify any number of variants in standard VCF format. The code is freely available as a dockerized workflow in GitHub (<ext-link xlink:href="https://github.com/diskin-lab-chop/AutoGVP" ext-link-type="uri">https://github.com/diskin-lab-chop/AutoGVP</ext-link>) with options of (1) supply a VEP-annotated VCF with ANNOVAR (<xref rid="btae114-B11" ref-type="bibr">Wang <italic toggle="yes">et al.</italic> 2010</xref>), AutoPVS1 (<xref rid="btae114-B12" ref-type="bibr">Xiang <italic toggle="yes">et al.</italic> 2020</xref>), and InterVar (<xref rid="btae114-B6" ref-type="bibr">Li and Wang 2017</xref>) outputs with the flexibility to update any of these and/or the provided ClinVar versions or (2) use similarly-annotated (ANNOVAR, InterVar, AutoPVS1, ClinVar) output from a cloud-based CAVATICA preprocessing workflow v.1.1.0 (<ext-link xlink:href="https://github.com/d3b-center/D3b-Pathogenicity-Preprocessing" ext-link-type="uri">https://github.com/d3b-center/D3b-Pathogenicity-Preprocessing</ext-link>) and public CAVATICA app (<ext-link xlink:href="https://cavatica.sbgenomics.com/public/apps/cavatica/apps-publisher/d3b-diskin-pathogenicity-preprocess-wf" ext-link-type="uri">https://cavatica.sbgenomics.com/public/apps/cavatica/apps-publisher/d3b-diskin-pathogenicity-preprocess-wf</ext-link>) on germline calls from the Kids First pipeline v.1.1.0 (<ext-link xlink:href="https://github.com/kids-first/kf-germline-workflow" ext-link-type="uri">https://github.com/kids-first/kf-germline-workflow</ext-link>) (<xref rid="btae114-F1" ref-type="fig">Fig. 1A</xref>). Depending on sample input size, AutoGVP can be run either locally, on Amazon Web Services Elastic Compute Cloud (AWS EC2), or on a high-performance computing (HPC) cluster.</p>
    <fig position="float" id="btae114-F1">
      <label>Figure 1.</label>
      <caption>
        <p>Flow diagram of AutoGVP. (A) Required input files for custom or CAVATICA workflow. (B) Variant classification method decision tree. (C) Alluvial plot showing how InterVar classification changes in AutoGVP. The large numbers of concordant VUS (357 656), LB (20 374), and B (28 310) variants were removed for easier visualization. Numbers in parentheses represent the number of variants in that classification. Panels (A) and (B) created with BioRender.com.</p>
      </caption>
      <graphic xlink:href="btae114f1" position="float"/>
    </fig>
  </sec>
  <sec>
    <title>2 Methods</title>
    <sec>
      <title>2.1 Data input and preparation</title>
      <p>AutoGVP is implemented in R and bash and is run within the Docker image: <ext-link xlink:href="https://pgc-images.sbgenomics.com/diskin-lab/autogvp:v1.0.0" ext-link-type="uri">https://pgc-images.sbgenomics.com/diskin-lab/autogvp:v1.0.0</ext-link>. Detailed instructions on how to run AutoGVP are documented within the README of the GitHub repository. The script requires the following input files that must be supplied by the user: a VCF file with VEP annotations (*VEP.vcf), a multianno file generated by ANNOVAR run with “—vcfinput” flag (*hg38_multianno.txt), an InterVar output file (*multianno.txt.intervar), and an AutoPVS1 output file (*autopvs1.txt). Additionally, it requires a ClinVar VCF file (clinvar.vcf.gz), variant summary file (variant_summary.txt.gz), and submission summary file (submission_summary.txt.gz) which can be downloaded directly from the ClinVar FTP site (<ext-link xlink:href="https://ftp.ncbi.nlm.nih.gov/pub/clinvar/" ext-link-type="uri">https://ftp.ncbi.nlm.nih.gov/pub/clinvar/</ext-link>) or are stably provided through the “download_clinvar.sh” script (ClinVar 7/17/2023 database). Alternative archived ClinVar version database files can also be supplied by the user. The “select-clinVar-submissions.R” script generates a subset of the ClinVar database prior to running AutoGVP. Several arguments allow for customization of 1-star conflicting variant resolution. The “—conceptID_list” flag takes a user-defined MedGen Concept ID list and filters variant submissions for only those associated with provided Concept IDs. As a use case, we supplied Concept IDs associated with cancer, though IDs for any disease can be used to identify P/LP variants specifically linked to the disease of interest. When conflicts cannot be resolved through consensus, users can specify whether to resolve with a Concept ID list by taking the call of the most recent submission (“—latest”) or the most severe call (“—most_severe”). Prior to running variant annotation, AutoGVP will minimally filter for PASS variants as well as any user-provided filters added in the “—filter_criteria” argument (e.g. minimum variant depth, variant allele frequency). Example test files for each workflow are provided within the GitHub repository as well as in the <xref rid="sup1" ref-type="supplementary-material">Supplementary Files</xref>.</p>
    </sec>
    <sec>
      <title>2.2 Variant annotation and classification</title>
      <p>AutoGVP uses a hierarchical system to integrate ClinVar and InterVar variant annotations (<xref rid="btae114-F1" ref-type="fig">Fig. 1B</xref>). ClinVar variant classifications have different levels of review status represented by stars ranging from zero to four (<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/clinvar/docs/review_status/#revstat" ext-link-type="uri">https://www.ncbi.nlm.nih.gov/clinvar/docs/review_status/#revstat</ext-link>) (<xref rid="btae114-B7" ref-type="bibr">Rehm <italic toggle="yes">et al.</italic> 2015</xref>). AutoGVP retains the ClinVar classification for variants with two or more stars or 1-star with criteria provided by a single submitter. Variants that have 1-star with criteria provided, but have conflicting interpretations, are resolved through a multi-step decision tree with user-defined options. First, all variant submissions with “no assertion criteria provided” are excluded from the resolution process. In the absence of a Concept ID list, AutoGVP will initially try to resolve conflicts by determining a majority call and will otherwise take the call of the most recent submission. When a Concept ID list is supplied, submissions will be filtered for only those associated with provided Concept IDs, and AutoGVP will again search for a majority call. Otherwise, conflicts will be resolved by taking the call of the most recent submission by default or if the “—latest” argument is specified, will take the most severe call if “—most_severe” is specified, in which order of Pathogenic (P), Likely Pathogenic (LP), Variant of Uncertain Significance (VUS), Likely Benign (LB), Benign (B) (<xref rid="btae114-F1" ref-type="fig">Fig. 1B</xref>). Variants with zero stars and variants that have non-standard P/LP/VUS/LB/B calls in ClinVar (ie, “Affects|risk_factor”, “association_not_found”, etc.) are treated as no ClinVar classification.</p>
      <p>Variants unclassified by the ClinVar database undergo classification by InterVar, which was modified in the following two ways. First, since ClinGen recommends using the LOF PVS1 rule with varying modifications of strength (<xref rid="btae114-B1" ref-type="bibr">Abou Tayoun <italic toggle="yes">et al.</italic> 2018</xref>), we adjusted InterVar output using AutoPVS1 calls (<xref rid="btae114-B12" ref-type="bibr">Xiang <italic toggle="yes">et al.</italic> 2020</xref>). Second, since exclusion of the PP5/BP6 criterion is now recommended to prevent potential misuse and double counting (<xref rid="btae114-B1" ref-type="bibr">Abou Tayoun <italic toggle="yes">et al.</italic> 2018</xref>, <xref rid="btae114-B3" ref-type="bibr">Biesecker <italic toggle="yes">et al.</italic> 2018</xref>), we removed those two rules from InterVar. Furthermore, InterVar use ClinVar to interpret the PP5 rule, and as a result, may capture a P/LP classification from Online Mendelian Inheritance in Man (OMIM: <ext-link xlink:href="https://www.omim.org/" ext-link-type="uri">https://www.omim.org/</ext-link>) or GeneReviews (<xref rid="btae114-B2" ref-type="bibr">Adam <italic toggle="yes">et al.</italic> 2023</xref>) (zero stars) when in essence there is no indication of the specific variants in those two sources.</p>
      <p>In summary, AutoGVP will generate a final call to be one of P/LP/VUS/LB/B based on the integration of the ClinVar and modified InterVar calls described above. AutoGVP modifies the InterVar classification using corrected PVS1 strength and completely removes PP5/BP6, per the most recent guidance from ClinGen. Lastly, AutoGVP will annotate variants to a single gene transcript by selecting the transcript annotation provided in AutoPVS1 file. Additional gene and transcript annotations, when present, are retained in the output column “csq_vep”. The software saves two output files per run: an abridged file with minimal columns including coordinate, gene annotation, and pathogenicity assessment information, and a full output file containing additional annotation columns from the input VCF, ANNOVAR, InterVar, and AutoPVS1 files. The current pipeline was tested using data from dbGaP phs000720.v4.p1, VEP 104, InterVar v.2.2.1, AutoPVS1 v.2.0, ClinVar database 10/28/23, and AutoGVP v1.0.0.</p>
    </sec>
  </sec>
  <sec sec-type="results">
    <title>Results</title>
    <p>To evaluate AutoGVP performance, we annotated 413,585 rare germline variants (gnomAD v3.1.1 non-cancer &lt;0.001) from 121 individuals with rhabdomyosarcoma (dbGaP phs000720.v4.p1)(<xref rid="btae114-B4" ref-type="bibr">Kim <italic toggle="yes">et al.</italic> 2021</xref>) using HPC and CAVATICA. Computational time and usage to annotate the above file using Concept ID with “—latest” flag for HPC is as follows: total of 10 minutes with 0.33 CPU hours, and 36.2GB RAM. For CAVATICA a total of 9.1 min with 0.01 CPU hours, and 37.7GB RAM were needed. Final AutoGVP Classification of both HPC and CAVATICA were identical. AutoGVP annotations were compared to InterVar alone (<xref rid="sup1" ref-type="supplementary-material">Supplementary Table S1</xref>). While we focused our evaluation on P/LP variants given their direct relevance to disease, we note that AutoGVP resolved many InterVar VUS calls into P, LP, B, LB (<xref rid="btae114-F1" ref-type="fig">Fig. 1C</xref>). Using AutoGVP without the specification of the MedGen Concept ID, we identified 353 P variants and 310 LP variants (total: 663 P/LP variants). Applying Concept IDs associated with cancer, we identified the same 353 P variants when either the “—latest” or “—most_ severe” options were used, but 311 LP variants for ‘—most_severe’ and 310 LP variants for ‘—latest’. One <italic toggle="yes">MEN1</italic> variant (<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/clinvar/variation/305302/" ext-link-type="uri">https://www.ncbi.nlm.nih.gov/clinvar/variation/305302/</ext-link>) was classified as LP in “most severe” but classified as VUS using latest or omitting Concept IDs. In contrast, 353 P and 366 LP variants (total: 719 P/LP variants) were identified using InterVar only. Despite the 56-variant difference in total P/LP count between AutoGVP vs. InterVar, when comparing at the variant level across P/LP/VUS/LB/B classifications, a total of 6770 variants were discordant. A total of 112 variants were P/LP by AutoGVP, but VUS/LB/B by InterVar. All 112 variants were found in ClinVar: 35 variants with more than 2-stars and 77 1-star classifications. Of the 1-star classifications, 37 came from a single submitter and 40 had conflicting submissions, which were resolved using either “consensus” or the “most recent evaluated date”. Conversely, there were 168 variants P/LP by InterVar, but VUS/LB/B by AutoGVP. Of those 168 variants, 91 were classified by ClinVar and 77 were classified by InterVar. Of the InterVar-classified variants, 76 were downgraded by AutoGVP due to PVS1 adjustments, and one variant that still retained PVS1 = 1 was demoted to VUS due to removal of PP5, highlighting the over-calling of P/LP variants by InterVar alone. Furthermore, we evaluated common variants to understand how many would be assigned a P/LP classification. Of the 244,085 variants that have gnomAD population max allele frequency greater than 1%, 27 variants (0.01%) were annotated as P/LP by AutoGVP. Out of these 27 variants, only one variant was classified as P/LP by InterVar, and the remaining 26/27 variants (96.3%) were classified as P/LP by ClinVar with no AutoGVP adjustment (<xref rid="sup1" ref-type="supplementary-material">Supplementary Table S2</xref>).</p>
  </sec>
  <sec>
    <title>3 Discussion</title>
    <p>Currently available germline sequence variant classification tools are limited by (1) the number of variants that can be classified, (2) the ability to classify only previously reported variants, (3) the ACMG-AMP rules being modified after the time of tool development, (4) the lack of integration with ClinVar, the most extensive and curated germline variant database, and (5) paywall restrictions. Therefore, we developed AutoGVP, an open-source dockerized R workflow that automatically integrates ClinVar and modified InterVar variant annotations with updated ACMG-AMP criteria to classify the pathogenicity of germline sequence variants for research applications. It is important to note that the AutoGVP modifications of InterVar reported here do <italic toggle="yes">not</italic> incorporate gene-specific classification rules developed by ClinGen VCEP. Thus, review of variant classification for genes that have undergone the VCEP process is highly recommended. Furthermore, the use of AutoGVP should be limited to germline analysis at this time. As ClinVar adds submissions for somatic variants, we anticipate future enhancements of AutoGVP to enable classification of somatic variation. AutoGVP can be applied to disease-agnostic germline datasets in a fully automated fashion. With the increasing availability of germline exome and genome sequencing data, we anticipate AutoGVP will become a valuable resource for the research community.</p>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary Material</title>
    <supplementary-material id="sup1" position="float" content-type="local-data">
      <label>btae114_Supplementary_Data</label>
      <media xlink:href="btae114_supplementary_data.zip"/>
    </supplementary-material>
  </sec>
</body>
<back>
  <sec>
    <title>Supplementary data</title>
    <p><xref rid="sup1" ref-type="supplementary-material">Supplementary data</xref> are available at <italic toggle="yes">Bioinformatics</italic> online.</p>
  </sec>
  <sec sec-type="COI-statement">
    <title>Conflict of interest</title>
    <p>None declared.</p>
  </sec>
  <sec>
    <title>Funding</title>
    <p>This work has been supported by the National Institutes of Health [R03CA230366 to S.J.D., R01CA237562 to S.J.D., U2CHL138346 to A.C.R., and R03CA287169 to S.J.D. and J.L.R.], the Intramural Research program of the Division of Cancer Epidemiology and Genetics, National Cancer Institute, and the Division of Neurosurgery at the Children’s Hospital of Philadelphia. This work was also funded by Gabriella Miller Kids First pilot funds and in part, utilized the computational resources of the NIH HPC Biowulf cluster (<ext-link xlink:href="http://hpc.nih.gov" ext-link-type="uri">http://hpc.nih.gov</ext-link>).</p>
  </sec>
  <sec sec-type="data-availability">
    <title>Data availability</title>
    <p>The raw germline data used for this manuscript are available upon data access request to dbGAP under accession phs000720.v4.p1. De-identified test data from the dbGAP dataset used for this manuscript are available within the AutoGVP repository at <ext-link xlink:href="https://github.com/diskin-lab-chop/AutoGVP" ext-link-type="uri">https://github.com/diskin-lab-chop/AutoGVP</ext-link> and in the online supplementary material. Code and test data are archived at 10.5281/zenodo.10790815.</p>
  </sec>
  <ref-list id="ref1">
    <title>References</title>
    <ref id="btae114-B1">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Abou Tayoun</surname><given-names>AN</given-names></string-name>, <string-name><surname>Pesaran</surname><given-names>T</given-names></string-name>, <string-name><surname>DiStefano</surname><given-names>MT</given-names></string-name></person-group>, <etal>et al</etal><article-title>Recommendations for interpreting the loss of function PVS1 ACMG/AMP variant criterion</article-title>. <source>Hum. Mutat</source><year>2018</year>;<volume>39</volume>:<fpage>1517</fpage>–<lpage>24</lpage>.<pub-id pub-id-type="pmid">30192042</pub-id></mixed-citation>
    </ref>
    <ref id="btae114-B2">
      <mixed-citation publication-type="other"><person-group person-group-type="author"><string-name><surname>Adam</surname><given-names>MP</given-names></string-name></person-group><etal>et al</etal><year>2023</year>. GeneReviews<sup>®</sup> University of Washington, Seattle.</mixed-citation>
    </ref>
    <ref id="btae114-B3">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Biesecker</surname><given-names>LG</given-names></string-name>, <string-name><surname>Harrison</surname><given-names>SM</given-names></string-name></person-group>, <collab>ClinGen Sequence Variant Interpretation Working Group</collab>. <article-title>The ACMG/AMP reputable source criteria for the interpretation of sequence variants</article-title>. <source>Genet. Med</source><year>2018</year>;<volume>20</volume>:<fpage>1687</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="pmid">29543229</pub-id></mixed-citation>
    </ref>
    <ref id="btae114-B4">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kim</surname><given-names>J</given-names></string-name>, <string-name><surname>Light</surname><given-names>N</given-names></string-name>, <string-name><surname>Subasri</surname><given-names>V</given-names></string-name></person-group><etal>et al</etal><article-title>Pathogenic germline variants in cancer susceptibility genes in children and young adults with rhabdomyosarcoma</article-title>. <source>JCO Precis Oncol</source><year>2021</year>;<volume>5</volume>:PO.20.00218.</mixed-citation>
    </ref>
    <ref id="btae114-B5">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kopanos</surname><given-names>C</given-names></string-name>, <string-name><surname>Tsiolkas</surname><given-names>V</given-names></string-name>, <string-name><surname>Kouris</surname><given-names>A</given-names></string-name></person-group><etal>et al</etal><article-title>VarSome: the human genomic variant search engine</article-title>. <source>Bioinformatics</source><year>2019</year>;<volume>35</volume>:<fpage>1978</fpage>–<lpage>80</lpage>.<pub-id pub-id-type="pmid">30376034</pub-id></mixed-citation>
    </ref>
    <ref id="btae114-B6">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Li</surname><given-names>Q</given-names></string-name>, <string-name><surname>Wang</surname><given-names>K.</given-names></string-name></person-group><article-title>InterVar: clinical interpretation of genetic variants by the 2015 ACMG-AMP guidelines</article-title>. <source>Am J Hum Genet</source><year>2017</year>;<volume>100</volume>:<fpage>267</fpage>–<lpage>80</lpage>.<pub-id pub-id-type="pmid">28132688</pub-id></mixed-citation>
    </ref>
    <ref id="btae114-B7">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Rehm</surname><given-names>HL</given-names></string-name>, <string-name><surname>Berg</surname><given-names>JS</given-names></string-name>, <string-name><surname>Brooks</surname><given-names>LD</given-names></string-name></person-group>, <collab>ClinGen</collab><etal>et al</etal><article-title>ClinGen—the clinical genome resource</article-title>. <source>N. Engl. J. Med</source><year>2015</year>;<volume>372</volume>:<fpage>2235</fpage>–<lpage>42</lpage>.<pub-id pub-id-type="pmid">26014595</pub-id></mixed-citation>
    </ref>
    <ref id="btae114-B8">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Richards</surname><given-names>S</given-names></string-name>, <string-name><surname>Aziz</surname><given-names>N</given-names></string-name>, <string-name><surname>Bale</surname><given-names>S</given-names></string-name></person-group>, <etal>et al</etal><article-title>Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for molecular pathology</article-title>. <source>Genet. Med</source><year>2015</year>;<volume>17</volume>:<fpage>405</fpage>–<lpage>24</lpage>.<pub-id pub-id-type="pmid">25741868</pub-id></mixed-citation>
    </ref>
    <ref id="btae114-B9">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Scott</surname><given-names>AD</given-names></string-name>, <string-name><surname>Huang</surname><given-names>K-L</given-names></string-name>, <string-name><surname>Weerasinghe</surname><given-names>A</given-names></string-name></person-group><etal>et al</etal><article-title>CharGer: clinical characterization of germline variants</article-title>. <source>Bioinformatics</source><year>2019</year>;<volume>35</volume>:<fpage>865</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="pmid">30102335</pub-id></mixed-citation>
    </ref>
    <ref id="btae114-B10">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Singer-Berk</surname><given-names>M</given-names></string-name>, <string-name><surname>Gudmundsson</surname><given-names>S</given-names></string-name>, <string-name><surname>Baxter</surname><given-names>S</given-names></string-name></person-group><etal>et al</etal><article-title>Advanced variant classification framework reduces the false positive rate of predicted loss-of-function variants in population sequencing data</article-title>. <source>Am J Hum Genet</source><year>2023</year>;<volume>110</volume>:<fpage>1496</fpage>–<lpage>508</lpage>.<pub-id pub-id-type="pmid">37633279</pub-id></mixed-citation>
    </ref>
    <ref id="btae114-B11">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname><given-names>K</given-names></string-name>, <string-name><surname>Li</surname><given-names>M</given-names></string-name>, <string-name><surname>Hakonarson</surname><given-names>H</given-names></string-name></person-group><etal>et al</etal><article-title>ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data</article-title>. <source>Nucleic Acids Res</source><year>2010</year>;<volume>38</volume>:<fpage>e164</fpage>.<pub-id pub-id-type="pmid">20601685</pub-id></mixed-citation>
    </ref>
    <ref id="btae114-B12">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Xiang</surname><given-names>J</given-names></string-name>, <string-name><surname>Peng</surname><given-names>J</given-names></string-name>, <string-name><surname>Baxter</surname><given-names>S</given-names></string-name></person-group><etal>et al</etal><article-title>AutoPVS1: an automatic classification tool for PVS1 interpretation of null variants</article-title>. <source>Hum Mutat</source><year>2020</year>;<volume>41</volume>:<fpage>1488</fpage>–<lpage>98</lpage>.<pub-id pub-id-type="pmid">32442321</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
